image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
157ada06900921db483a5f11c7a2a07b742a4a98b5dbef2e588bea0f56a5b106.png | simple | <table><tr><td>Type of complication </td><td>Prevalence <i>N</i> (%)</td></tr><tr><td>Retinopathy</td><td>6 (0.9)</td></tr><tr><td>LVH</td><td>12 (2)</td></tr><tr><td>IHD</td><td>51 (8.3)</td></tr><tr><td>HF</td><td>75 (12.2)</td></tr><tr><td>CKD</td><td>20 (3.3)</td></tr><tr><td>Hypertensive urgency</td><td>39 (6.4)</... | <table><tr><td>Type of complication</td><td>Prevalence N (%)</td></tr><tr><td>Retinopathy</td><td>6 (0.9)</td></tr><tr><td>LVH</td><td>12 (2)</td></tr><tr><td>IHD</td><td>51 (8.3)</td></tr><tr><td>HF</td><td>75 (12.2)</td></tr><tr><td>CKD</td><td>20 (3.3)</td></tr></table> | <table><tr><td>Hypertensive urgency</td><td>39 (6.4)</td></tr><tr><td>Sexual dysfunction</td><td>4 (0.67)</td></tr><tr><td>Stroke</td><td>34 (5.5)</td></tr><tr><td>AF</td><td>6 (0.9)</td></tr><tr><td>Total TOD</td><td>247 (100.0)</td></tr></table> |
0c4a7ac7a349f8d94950880e065badff4fd02d7062c789f87868260d5f2a2b2a.png | simple | <table><tr><td>Parameters</td><td>Total (N = 268 )</td><td>Test (N = 134)</td><td>Control (N = 134)</td><td>P value</td></tr><tr><td>Female</td><td>110</td><td>57</td><td>53</td><td>0.619</td></tr><tr><td>Age (months)*</td><td>46.3 ± 30.3</td><td>44.5 ± 29.6</td><td>48.13 ± 31.1</td><td>0.331</td></tr><t... | <table><tr><td>Parameters</td><td>Total (N = 268 )</td><td>Test (N = 134)</td><td>Control (N = 134)</td><td>P value</td></tr><tr><td>Female</td><td>110</td><td>57</td><td>53</td><td>0.619</td></tr><tr><td>Age (months)*</td><td>46.3 ± 30.3</td><td>44.5 ± 29.6</td><td>48.13 ± 31.1</td><td>0.331</td></tr><tr><td>12–17</td... | <table><tr><td>Parameters</td><td>Total (N = 268 )</td><td>Test (N = 134)</td><td>Control (N = 134)</td><td>P value</td></tr><tr><td>TLC (mm3)*</td><td>10,762.3 ± 3,466.5</td><td>11,062.0 ± 3,627.3</td><td>10,462.7 ± 3,284.0</td><td>0.157</td></tr><tr><td>Neutrophils (%) *</td><td>42.1 ± 13.0</td><td>42.6 ± 13.9</td><t... |
538453cf37586177867020487c1c6aef7ae65c1fe38d9ce1400fe12576a15087.png | complex | <table><tr><td>Variable</td><td>Active group</td><td>Control group</td><td>df</td><td>x2/ T</td><td>P</td></tr><tr><td> </td><td>N = 80</td><td>N = 80</td><td> </td><td> </td><td> </td></tr><tr><td>Age* (y)</td><td>63.66 ± 6.37</td><td>63.1 ± 6.85</td><td>158</td><td>−0.53</td><td>0.59</td></tr><tr><td>... | <table><tr><td>Variable</td><td>Active group</td><td>Control group</td><td>df</td><td>x2/ T</td><td>P</td></tr><tr><td></td><td>N = 80</td><td>N = 80</td><td></td><td></td><td></td></tr><tr><td>Age* (y)</td><td>63.66 ± 6.37</td><td>63.1 ± 6.85</td><td>158</td><td>−0.53</td><td>0.59</td></tr><tr><td>Sex (n%)</td><td></t... | <table><tr><td>Variable</td><td>Active group</td><td>Control group</td><td>df</td><td>x2/ T</td><td>P</td></tr><tr><td></td><td>N = 80</td><td>N = 80</td><td></td><td></td><td></td></tr><tr><td>Foot care practice*</td><td>4.77 ± 0.77</td><td>4.45 ± 0.83</td><td>158</td><td>−2.54</td><td>0.01</td></tr><tr><td colspan="2... |
d164aa97ed18e2f5c0f739a045191ab46aed959a0a1a9c7f5f67edd18ace3a8b.png | complex | <table><tr><td rowspan="2">Treatment</td><td rowspan="2">Conc. (μg/ml)</td><td colspan="2">Mean absorbance ± SD</td><td rowspan="2">Percentage inhibition of haemolysis</td></tr><tr><td>Heated solution</td><td>Unheated solution</td></tr><tr><td>Control</td><td>-</td><td>0.67 ± 0.13</td><td>0.3 ± 0.01... | <table><tr><td rowspan="2">Treatment</td><td rowspan="2">Conc. (μg/ml)</td><td colspan="2">Mean absorbance ± SD</td><td rowspan="2">Percentage inhibition of haemolysis</td></tr><tr><td>Heated solution</td><td>Unheated solution</td></tr><tr><td>Control</td><td>-</td><td>0.67 ± 0.13</td><td>0.3 ± 0.01</td><td></td></tr><... | <table><tr><td rowspan="2">Treatment</td><td rowspan="2">Conc. (μg/ml)</td><td colspan="2">Mean absorbance ± SD</td><td rowspan="2">Percentage inhibition of haemolysis</td></tr><tr><td>Heated solution</td><td>Unheated solution</td></tr><tr><td rowspan="2">Extract</td><td>400</td><td>0.42 ± 0. 07**</td><td>0.12 ± 0.03</... |
0d64dc1534a641bbd5ccc430462fc4e06e42ee96ad8004c681e11eb5a0942e5d.png | complex | <table><tr><td rowspan="2">Malalignment parameter</td><td colspan="2">Difference compared to pre-opMedian (IQR)</td><td rowspan="2">Significance<sup>a</sup></td></tr><tr><td>Cutting guide (<i>n</i> = 4)</td><td>Visualisation (<i>n</i> = 4)</td></tr><tr><td>Coronal shift in mm, ulnar (−), radial (+)</td><td>3.1 (1... | <table><tr><td rowspan="2">Malalignment parameter</td><td>Difference compared to pre-opMedian (IQR)</td></tr><tr><td>Cutting guide (n = 4)</td></tr><tr><td>Coronal shift in mm, ulnar (−), radial (+)</td><td>3.1 (1.9 to 10.0)</td></tr><tr><td>Sagittal shift in mm, volar (−), dorsal (+)</td><td>10.2 (−7.3 to 18.1)</td></... | <table><tr><td>Difference compared to pre-opMedian (IQR)</td><td rowspan="2">Significancea</td></tr><tr><td>Visualisation (n = 4)</td></tr><tr><td>−2.6 (−3.0 to 3.5)</td><td>0.200</td></tr><tr><td>−6.7 (−26.4 to −2.6)</td><td>0.200</td></tr><tr><td>4.3 (0.3 to 5.4)</td><td>0.686</td></tr><tr><td>8.5 (5.2 to 14.9)</td><... |
afef55cfc383a5cc87eb4cc5ac75db744cc33312b54171340ce32ba2241cb265.png | complex | <table><tr><td rowspan="2">Analyte</td><td colspan="2">Concn (ng/ml)</td></tr><tr><td>Low</td><td>High</td></tr><tr><td>Amodiaquine</td><td>4.0</td><td>4,192</td></tr><tr><td>Desethylamodiaquine</td><td>4.0</td><td>4,192</td></tr><tr><td>Lumefantrine</td><td>25</td><td>20,000</td></tr><tr><td>Chloroquine</td><td>4.0</t... | <table><tr><td rowspan="2">Analyte</td><td colspan="2">Concn (ng/ml)</td></tr><tr><td>Low</td><td>High</td></tr><tr><td>Amodiaquine</td><td>4.0</td><td>4,192</td></tr><tr><td>Desethylamodiaquine</td><td>4.0</td><td>4,192</td></tr><tr><td>Lumefantrine</td><td>25</td><td>20,000</td></tr></table> | <table><tr><td>Chloroquine</td><td>4.0</td><td>4,192</td></tr><tr><td>Desethylchloroquine</td><td>4.0</td><td>4,192</td></tr><tr><td>Dihydroartemisinin</td><td>1.6</td><td>2,875</td></tr><tr><td>Piperaquine</td><td>1.2</td><td>575</td></tr><tr><td>Mefloquine</td><td>70</td><td>4,000</td></tr><tr><td>Carboxymefloquine</... |
a2c46f331cb8b0ea0c18f626c2ce4ed7ad185366d8a0be20910abaf174a872bf.png | complex | <table><tr><td></td><td>Panitumumab + mFOLFOX6 (<i>n =</i> 88)</td><td>Bevacizumab + mFOLFOX6 (<i>n =</i> 82)*</td></tr><tr><td>Median DoR, months (95% CI)</td><td>11.4 (10.0, 16.3)</td><td>9.0 (7.6, 9.5)</td></tr><tr><td> HR<sup>†</sup> (95% CI)</td><td colspan="2">0.59 (0.39, 0.88)</td></tr><tr><td> <i>p</i> va... | <table><tr><td></td><td>Panitumumab + mFOLFOX6 (n = 88)</td><td>Bevacizumab + mFOLFOX6 (n = 82)*</td></tr><tr><td>Median DoR, months (95% CI)</td><td>11.4 (10.0, 16.3)</td><td>9.0 (7.6, 9.5)</td></tr><tr><td>HR† (95% CI)</td><td colspan="2">0.59 (0.39, 0.88)</td></tr><tr><td>p value‡</td><td colspan="2">0.011</td></tr>... | <table><tr><td></td><td>Panitumumab + mFOLFOX6 (n = 88)</td><td>Bevacizumab + mFOLFOX6 (n = 82)*</td></tr><tr><td>p value¶</td><td colspan="2">0.0018</td></tr><tr><td>Any resection, n (%)</td><td>12 (14)</td><td>9 (11)</td></tr><tr><td>Liver only§</td><td>9 (75)</td><td>6 (67)</td></tr><tr><td>Complete resection</td><t... |
5eef7cfa67dc704b5f28d70970bfb031560f099030698fdf59d4c350932fda42.png | complex | <table><tr><td> </td><td> </td><td colspan="3">High-risk subject</td><td colspan="4">Low-risk subject</td></tr><tr><td> </td><td> </td><td>N</td><td>Mean<sup>a</sup></td><td>CI</td><td>N</td><td>Mean<sup>a</sup></td><td>CI</td><td>P</td></tr><tr><td><i>Women</i></td><td> </td><td> </td><td> </td><td> </td><td> </td><td... | <table><tr><td></td><td></td><td colspan="3">High-risk subject</td><td colspan="4">Low-risk subject</td></tr><tr><td></td><td></td><td>N</td><td>Meana</td><td>CI</td><td>N</td><td>Meana</td><td>CI</td><td>P</td></tr></table> | <table><tr><td>Women</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>.022</td></tr><tr><td rowspan="2"></td><td>Divorced</td><td>118</td><td>.51</td><td>.36–.67</td><td>516</td><td>.20</td><td>.13–.26</td><td></td></tr><tr><td>Not divorced</td><td>1051</td><td>.07</td><td>.01–.12</td><td>11068</t... |
d5945e7028169a7202f6b545ce70ff207109c0879849237ae0a1621b134c046a.png | simple | <table><tr><td>Gene</td><td>Encoded protein</td><td>Fold change</td><td>Cell cycle</td></tr><tr><td>AURKA</td><td>Aurora kinase A</td><td>−2.712</td><td>STOP</td></tr><tr><td>AURKB</td><td>Aurora kinase B</td><td>−4.146</td><td>STOP</td></tr><tr><td>CCNA2</td><td>Cyclin A2</td><td>−4.652</td><td>STOP<... | <table><tr><td>Gene</td><td>Encoded protein</td><td>Fold change</td><td>Cell cycle</td></tr><tr><td>AURKA</td><td>Aurora kinase A</td><td>−2.712</td><td>STOP</td></tr><tr><td>AURKB</td><td>Aurora kinase B</td><td>−4.146</td><td>STOP</td></tr><tr><td>CCNA2</td><td>Cyclin A2</td><td>−4.652</td><td>STOP</td></tr><tr><td>C... | <table><tr><td>CENPF</td><td>Centromere protein F, 350/400 kDa</td><td>−3.927</td><td>STOP</td></tr><tr><td>CENPI</td><td>Centromere protein I</td><td>−2.899</td><td>STOP</td></tr><tr><td>CENPK</td><td>Centromere protein K</td><td>−2.813</td><td>STOP</td></tr><tr><td>CENPL</td><td>Centromere protein L</td><td>−1.864</t... |
485055b527c04212475eba00c45cb53d1c8fa73a578bb4251a01a82b238de8a0.png | simple | <table><tr><td></td><td>Criteria</td><td>Assessment</td></tr><tr><td>1</td><td>A diagnosis of PD</td><td>Queen's Square Brain Bank Criteria</td></tr><tr><td>2</td><td>PD developed prior to the onset of dementia</td><td>Patient/caregiver history or ancillary records</td></tr><tr><td>3</td><td>PD associated with a decrea... | <table><tr><td></td><td>Criteria</td><td>Assessment</td></tr><tr><td>1</td><td>A diagnosis of PD</td><td>Queen's Square Brain Bank Criteria</td></tr><tr><td>2</td><td>PD developed prior to the onset of dementia</td><td>Patient/caregiver history or ancillary records</td></tr><tr><td>3</td><td>PD associated with a decrea... | <table><tr><td></td><td>Criteria</td><td>Assessment</td></tr><tr><td>4</td><td>deficiency severe enough to impair daily life</td><td>ew or pill questionnaire</td></tr><tr><td>5</td><td>Impairment of more than one cognitive domain</td><td>Impairment of at least two of the following domains</td></tr><tr><td></td><td></td... |
7589227fff4dd418cfe7fa45645c783eab26d7ed86fefb7985b4d590b88d9503.png | simple | <table><tr><td>Case/sex/age (years)</td><td>Initial treatment</td><td>Associated pseudocyst</td><td>Rebleeding</td><td>Secondary treatment</td><td>Length of follow-up (months)</td><td>Outcome</td></tr><tr><td>1/M/59</td><td>A</td><td>No</td><td>No</td><td>No</td><td>57</td><td>S</td></tr><tr><td>2/M/33</td><td>TG, L</t... | <table><tr><td>Case/sex/age (years)</td><td>Initial treatment</td><td>Associated pseudocyst</td><td>Rebleeding</td></tr><tr><td>1/M/59</td><td>A</td><td>No</td><td>No</td></tr><tr><td>2/M/33</td><td>TG, L</td><td>No</td><td>No</td></tr><tr><td>3/M/46</td><td>E</td><td>Yes*</td><td>Yes</td></tr><tr><td>4/F/71</td><td>E<... | <table><tr><td>Secondary treatment</td><td>Length of follow-up (months)</td><td>Outcome</td></tr><tr><td>No</td><td>57</td><td>S</td></tr><tr><td>No</td><td>38</td><td>S</td></tr><tr><td>E‡, L, ED</td><td>4</td><td>D</td></tr><tr><td>E</td><td>18</td><td>S</td></tr><tr><td>No</td><td>50</td><td>S</td></tr><tr><td>E‡, L... |
811d341a37d0fc9f21fd34a59879e961a07fe8739e81144220edd01483d8a5f5.png | complex | <table><tr><td>Materials</td><td colspan="3">Size (L = Length; W = Width; H = Height)</td></tr><tr><td>Grinding media</td><td>Steel ball (∅15 mm)</td><td>Square (L: 12 × W: 12 × H: 12 mm)</td><td>Cylinder (∅12 × H: 16 mm)</td></tr><tr><td>Iron ore particle</td><td colspan="3">2–2.8 mm</... | <table><tr><td>Materials</td></tr><tr><td>Grinding media</td></tr><tr><td>Iron ore particle</td></tr><tr><td>Lifter</td></tr></table> | <table><tr><td colspan="3">Size (L = Length; W = Width; H = Height)</td></tr><tr><td>Steel ball (∅15 mm)</td><td>Square (L: 12 × W: 12 × H: 12 mm)</td><td>Cylinder (∅12 × H: 16 mm)</td></tr><tr><td colspan="3">2–2.8 mm</td></tr><tr><td>L: 40 × W: 20 × H: 10 mm</td><td>L: 40 × W: 20 × H: 15 mm</td><td>L: 40 × W: 20 × H:... |
d195e7a265f6d78e75804cfc4af6bd3bb9eb98eb5703b0b2a9e77c927fbcbbc8.png | complex | <table><tr><td rowspan="2">Variables</td><td>TSH 0.40–2.49 mIU/L</td><td>TSH 2.50–4.99</td><td rowspan="2"><i>p-</i>value</td></tr><tr><td>(<i>n</i> = 26)</td><td>(<i>n</i> = 12)</td></tr><tr><td>Intrauterine fetal death</td><td>2 (7.7%)</td><td>0</td><td>1.00</td></tr><tr><td>Preterm birth</td><td>2 (7.7%)... | <table><tr><td rowspan="2">Variables</td><td>TSH 0.40–2.49 mIU/L</td><td>TSH 2.50–4.99</td><td rowspan="2">p-value</td></tr><tr><td>(n = 26)</td><td>(n = 12)</td></tr><tr><td>Intrauterine fetal death</td><td>2 (7.7%)</td><td>0</td><td>1.00</td></tr><tr><td>Preterm birth</td><td>2 (7.7%)</td><td>1 (8.3%)</td><td>1.00</t... | <table><tr><td rowspan="2">Variables</td><td>TSH 0.40–2.49 mIU/L</td><td>TSH 2.50–4.99</td><td rowspan="2">p-value</td></tr><tr><td>(n = 26)</td><td>(n = 12)</td></tr><tr><td>irth</td><td>(84.6%)</td><td>%)</td><td>5</td></tr><tr><td>Duration of gestation (d)</td><td>263.83 ± 15.8</td><td>266.6 ± 19.6</td><td>0.66</td>... |
5cddea329055b359b87b58eb57560ca20d53fd53208ed7f097d0e7314f61accf.png | complex | <table><tr><td></td><td colspan="4">Newly referred patients</td><td colspan="4">Long-term follow-up patients</td></tr><tr><td></td><td>Level 1 (<i>n</i> = 9)</td><td>Level 2 (<i>n</i> = 125)</td><td>Level 3 (<i>n</i> = 111)</td><td>All (<i>n</i> = 245)</td><td>Level 1 (<i>n</i> = 18)</td><td>Level 2 (<i>n</i> = 236)</t... | <table><tr><td></td><td colspan="4">Newly referred patients</td><td colspan="4">Long-term follow-up patients</td></tr><tr><td></td><td>Level 1 (n = 9)</td><td>Level 2 (n = 125)</td><td>Level 3 (n = 111)</td><td>All (n = 245)</td><td>Level 1 (n = 18)</td><td>Level 2 (n = 236)</td><td>Level 3 (n = 165)</td><td>All (n = 4... | <table><tr><td>proliferative retinopathy</td><td>0</td><td>0</td><td>3 (2.7)</td><td>3 (1.2)</td><td>0</td><td>0</td><td>4 (2.4)</td><td>4 (1.0)</td></tr><tr><td>Neuropathy – no. (%)</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Peripheral neuropathy or insufficiency</td><td>0... |
633c982e8df4c5daf0cfca3f3e09abccbf33e0e3e70e067e238e0c981604fedd.png | complex | <table><tr><td rowspan="3">Number of examined samples</td><td colspan="2">n (%)</td></tr><tr><td>Pure buffalo samples</td><td>Adulterated samples</td></tr><tr><td>50</td><td>5 (10)</td><td>45 (90)</td></tr></table> | <table><tr><td rowspan="2">Number of examined samples</td><td colspan="2">n (%)</td></tr><tr><td>Pure buffalo samples</td><td>Adulterated samples</td></tr></table> | <table><tr><td>Number of examined samples</td><td colspan="2"></td></tr><tr><td>50</td><td>5 (10)</td><td>45 (90)</td></tr></table> |
b62778fdc2283365baddeeae3d9bb7dc7807aeb97245ef988ab55033925057f3.png | complex | <table><tr><td>SI</td><td></td><td colspan="3">Prediction method</td><td></td><td></td></tr><tr><td><i>Feature selection method</i></td><td><i># of SNP</i></td><td><i>LR</i></td><td><i>SVM</i></td><td><i>RF</i></td><td><i>EN</i></td><td><i>LDA</i></td></tr><tr><td>LR</td><td>100</td><td>0.7597</td><td>0.7171</td><td>0.... | <table><tr><td>SI</td><td></td><td colspan="3">Prediction method</td><td></td><td></td></tr><tr><td>Feature selection method</td><td># of SNP</td><td>LR</td><td>SVM</td><td>RF</td><td>EN</td><td>LDA</td></tr><tr><td>LR</td><td>100</td><td>0.7597</td><td>0.7171</td><td>0.7067</td><td>0.7670</td><td>0.7605</td></tr><tr><... | <table><tr><td></td><td>500</td><td>0.7953</td><td>0.8178</td><td>0.6930</td><td>0.7943</td><td>0.8075</td></tr><tr><td>RF</td><td>100</td><td>0.5961</td><td>0.6101</td><td>0.5980</td><td>0.5848</td><td>0.5957</td></tr><tr><td></td><td>500</td><td>0.6185</td><td>0.6312</td><td>0.6138</td><td>0.6010</td><td>0.6210</td><... |
b358f9ac2caefc799fda3d8921ddf571d7fe1df4aca70e3a168eff4ac51c3c94.png | complex | <table><tr><td>Menopausal symptoms</td><td>Number (%)</td><td>Severe</td><td>Very severe</td></tr><tr><td colspan="4">Somatic</td></tr><tr><td>Sleeping problems</td><td>574 (78.7)</td><td>93</td><td>1</td></tr><tr><td>Hot flushes, sweating</td><td>508 (69.7)</td><td>157</td><td>75</td></tr><tr><td>Joint and muscular di... | <table><tr><td>Menopausal symptoms</td><td>Number (%)</td><td>Severe</td><td>Very severe</td></tr><tr><td colspan="4">Somatic</td></tr><tr><td>Sleeping problems</td><td>574 (78.7)</td><td>93</td><td>1</td></tr><tr><td>Hot flushes, sweating</td><td>508 (69.7)</td><td>157</td><td>75</td></tr><tr><td>Joint and muscular di... | <table><tr><td colspan="4">Urogenital</td></tr><tr><td>Dryness of vagina</td><td>449 (61.6)</td><td>102</td><td>4</td></tr><tr><td>Bladder problems</td><td>385 (52.8)</td><td>38</td><td>2</td></tr><tr><td>Sexual problems</td><td>343 (47.1)</td><td>56</td><td>6</td></tr></table> |
6cd7d20d0d54d35fb74369966bcd42e4ca088fefd260584ca2977e729f090198.png | simple | <table><tr><td>Variable</td><td>No post-pyloric tubeMedian (IQR)</td><td>Post-pyloric tubeMedian (IQR)</td></tr><tr><td>Age</td><td>53 (42-64)</td><td>56 (40-67)</td></tr><tr><td>Sex (M:F)</td><td>35:29</td><td>19:25</td></tr><tr><td>APACHE II score</td><td>26 (21-31.5)</td><td>28.5 (22.5-33.5)</td></tr><tr><td>Length ... | <table><tr><td>Variable</td><td>No post-pyloric tubeMedian (IQR)</td><td>Post-pyloric tubeMedian (IQR)</td></tr></table> | <table><tr><td>Age</td><td>53 (42-64)</td><td>56 (40-67)</td></tr><tr><td>Sex (M:F)</td><td>35:29</td><td>19:25</td></tr><tr><td>APACHE II score</td><td>26 (21-31.5)</td><td>28.5 (22.5-33.5)</td></tr><tr><td>Length of stay in days</td><td>4.97 (2.0-10.0)</td><td>5.57 (2.8-9.8)</td></tr><tr><td>Ventilator days</td><td>3... |
0cb9fd73cfb7818d68a0f28816661937ec2c99180d8c606c9ee357793063bee0.png | simple | <table><tr><td>Reading Task</td><td>Times New Roman</td><td>EasyReadingTM</td></tr><tr><td>Excerpt (<i>t</i><sub>(531)</sub> = −32.12, <i>p</i> < 0.001) </td><td>3.50 ± 0.94 </td><td>4.16 ± 1.09 </td></tr><tr><td>Words (<i>t</i><sub>(532)</sub> = −18.14, <i>p</i> < 0.001) </td><td>3.03 ±... | <table><tr><td>Reading Task</td><td>Times New Roman</td><td>EasyReadingTM</td></tr><tr><td>Excerpt (t(531) = −32.12, p < 0.001)</td><td>3.50 ± 0.94</td><td>4.16 ± 1.09</td></tr></table> | <table><tr><td>Reading Task</td><td>Times New Roman</td><td>EasyReadingTM</td></tr><tr><td>Words (t(532) = −18.14, p < 0.001)</td><td>3.03 ± 0.88</td><td>3.33 ± 0.93</td></tr><tr><td>Non-words (t(532) = −10.37, p < 0.001)</td><td>1.86 ± 0.60</td><td>2.04 ± 0.61</td></tr></table> |
3a3ddbe917a355959ab467c857dff0cb31a652231391bcc1fe19ec4daa4aa64a.png | simple | <table><tr><td>Mechanism</td><td>Source</td><td>Description</td></tr><tr><td>Soluble CD25</td><td>RS cells</td><td>Prevent interaction of IL-2 with IL-2Rs</td></tr><tr><td>IL-10</td><td>RS cells, Tregs, cells of TME</td><td>Repress IL-2 and IFN-γ production</td></tr><tr><td>TGF-β</td><td>RS cells, Tregs, cell... | <table><tr><td>Mechanism</td><td>Source</td><td>Description</td></tr><tr><td>Soluble CD25</td><td>RS cells</td><td>Prevent interaction of IL-2 with IL-2Rs</td></tr><tr><td>IL-10</td><td>RS cells, Tregs, cells of TME</td><td>Repress IL-2 and IFN-γ production</td></tr><tr><td>TGF-β</td><td>RS cells, Tregs, cells of TME</... | <table><tr><td>MHC-I</td><td>RS cells (EBV+)</td><td>Bind to KIRs, inhibit NK cell activation</td></tr></table> |
a4a6bf5e7116aabb9a2206f98bf6a71a7984aa3b75822b971925155a8af2ae2c.png | complex | <table><tr><td> </td><td>PTSD Prevalence</td><td>War victims</td><td>Crime victims</td><td>Natural disaster</td><td>Road fatalities</td></tr><tr><td>PTSD Prevalence</td><td>-</td><td>0.87***</td><td>0.69*</td><td>0.29</td><td>-0.16</td></tr><tr><td>War victims</td><td> </td><td>-</td><td>0.73*</td><td>0.57*</td><td>0.2... | <table><tr><td></td><td>PTSD Prevalence</td></tr><tr><td>PTSD Prevalence</td><td>-</td></tr><tr><td>War victims</td><td></td></tr><tr><td>Crime victims</td><td></td></tr><tr><td>Natural disaster</td><td></td></tr><tr><td>Road fatalities</td><td></td></tr><tr><td>Individual values</td><td></td></tr><tr><td>Security</td>... | <table><tr><td>War victims</td><td>Crime victims</td><td>Natural disaster</td><td>Road fatalities</td></tr><tr><td>0.87***</td><td>0.69*</td><td>0.29</td><td>-0.16</td></tr><tr><td>-</td><td>0.73*</td><td>0.57*</td><td>0.22</td></tr><tr><td></td><td>-</td><td>0.48</td><td>-0.08</td></tr><tr><td></td><td></td><td>-</td>... |
f5d47d7732ef780159a9f1a7b63cfdbca123ec1d89692c74730594c28a39667e.png | complex | <table><tr><td> </td><td colspan="3">Controls</td><td colspan="3">Cases</td></tr><tr><td> </td><td>All</td><td>Male</td><td>Female</td><td>All</td><td>Male</td><td>Female</td></tr><tr><td>CAD</td><td>2292</td><td>1245(0.54)</td><td>1047(0.46)</td><td>2323</td><td>1777(0.76)</td><td>546(0.24)</td></tr><tr><td>MI</td><td... | <table><tr><td></td><td colspan="3">Controls</td><td colspan="3">Cases</td></tr><tr><td></td><td>All</td><td>Male</td><td>Female</td><td>All</td><td>Male</td><td>Female</td></tr><tr><td>CAD</td><td>2292</td><td>1245(0.54)</td><td>1047(0.46)</td><td>2323</td><td>1777(0.76)</td><td>546(0.24)</td></tr><tr><td>MI</td><td>8... | <table><tr><td></td><td colspan="3">Controls</td><td colspan="3">Cases</td></tr><tr><td></td><td>All</td><td>Male</td><td>Female</td><td>All</td><td>Male</td><td>Female</td></tr><tr><td>Total Chol</td><td>4.51 ± 0.02</td><td>4.42 ± 0.03</td><td>4.62 ± 0.03</td><td>4.48 ± 0.02</td><td>4.43 ±0.03</td><td>4.66 ± 0.05</td>... |
6e87ab5e74c4b99ad154fecd9e5b9ea54687fbf1ab617289ace7567280ddc244.png | simple | <table><tr><td>Range of ages (months)</td><td>Average age (SD)</td><td>Rang of intelligibility</td><td>Average intelligibility scores (SD)</td></tr><tr><td>48–59</td><td>CI: 51.66 (3.87)N: 54.15 (3.69)</td><td>CI: 56–100</td><td>68.52 (1.47)100 (0.00)</td></tr><tr><td>60–71</td><td>CI: 64.25 (4.19)N: ... | <table><tr><td>Range of ages (months)</td><td>Average age (SD)</td><td>Rang of intelligibility</td><td>Average intelligibility scores (SD)</td></tr></table> | <table><tr><td>48–59</td><td>CI: 51.66 (3.87)N: 54.15 (3.69)</td><td>CI: 56–100</td><td>68.52 (1.47)100 (0.00)</td></tr><tr><td>60–71</td><td>CI: 64.25 (4.19)N: 65.75 (3.27)</td><td>CI: 58.46–63.07</td><td>60.76 (1.97)100 (0.00)</td></tr><tr><td>72–83</td><td>CI: 76.57 (2.87)N: 75.55 (3.67)</td><td>CI: 55.38–66.15</td>... |
aeeffdfe91dabe824a388bca84010c542b18df1aad51a9111059987878bcbf3b.png | simple | <table><tr><td>Variables</td><td>Lower-Grade Glioma</td><td>Glioblastoma</td></tr><tr><td>Numbers</td><td>170</td><td>133</td></tr><tr><td>Median age (range)</td><td>39 (10–75)</td><td>49 (8–81)</td></tr><tr><td>Sex (male)</td><td>103</td><td>86</td></tr><tr><td>Pathology (Astrocytic)</td><td>69</td><td>-</... | <table><tr><td>Variables</td></tr><tr><td>Numbers</td></tr><tr><td>Median age (range)</td></tr><tr><td>Sex (male)</td></tr><tr><td>Pathology (Astrocytic)</td></tr><tr><td>IDH1 mutational status</td></tr><tr><td>IDH1 mutation</td></tr><tr><td>IDH1 wild-type</td></tr><tr><td>1p/19q status</td></tr><tr><td>1p/19q co-delet... | <table><tr><td>Lower-Grade Glioma</td><td>Glioblastoma</td></tr><tr><td>170</td><td>133</td></tr><tr><td>39 (10–75)</td><td>49 (8–81)</td></tr><tr><td>103</td><td>86</td></tr><tr><td>69</td><td>-</td></tr><tr><td>-</td><td>-</td></tr><tr><td>100</td><td>18</td></tr><tr><td>34</td><td>78</td></tr><tr><td>-</td><td>-</td... |
b3f4e53f3ca95bbc5dd2059311ae94a1d66f13d7231da23bf964603fca05dc80.png | complex | <table><tr><td colspan="2"> </td><td colspan="8">Age at death (years)</td></tr><tr><td colspan="2"> </td><td colspan="2">Never smoked</td><td colspan="2">Light smoker</td><td colspan="2">Medium smoker</td><td colspan="2">Heavy smoker</td></tr><tr><td colspan="2">Predicted survival percentile<sup>1</sup></td><td>Men</td... | <table><tr><td colspan="2"></td><td colspan="8">Age at death (years)</td></tr><tr><td colspan="2"></td><td colspan="2">Never smoked</td><td colspan="2">Light smoker</td><td colspan="2">Medium smoker</td><td colspan="2">Heavy smoker</td></tr><tr><td colspan="2">Predicted survival percentile1</td><td>Men</td><td>Women</t... | <table><tr><td>45 years</td><td>5%</td><td>55.25</td><td>58.92</td><td>54.00</td><td>55.00</td><td>52.00</td><td>53.92</td><td>51.17</td><td>90.50</td></tr><tr><td></td><td>50%</td><td>78.50</td><td>84.33</td><td>75.92</td><td>78.42</td><td>72.08</td><td>76.75</td><td>70.33</td><td>76.50</td></tr><tr><td></td><td>95%</... |
fcc97f5bf274c3dded881a26a6b9e6e709cb74ef1c66874d7c2c0c4035c7b21d.png | complex | <table><tr><td>Characteristic</td><td>N (%) or Mean ± SD</td></tr><tr><td colspan="2">Sex</td></tr><tr><td> Female</td><td>183 (70.4 %)</td></tr><tr><td> Male</td><td>77 (29.6 %)</td></tr><tr><td>Age (years)</td><td>38.8 (13.7)</td></tr><tr><td colspan="2">Referral source</td></tr><tr><td> Primary Care</td><td>231... | <table><tr><td>Characteristic</td><td>N (%) or Mean ± SD</td></tr><tr><td colspan="2">Sex</td></tr><tr><td>Female</td><td>183 (70.4 %)</td></tr><tr><td>Male</td><td>77 (29.6 %)</td></tr><tr><td>Age (years)</td><td>38.8 (13.7)</td></tr><tr><td colspan="2">Referral </td></tr></table> | <table><tr><td>Characteristic</td><td>N (%) or Mean ± SD</td></tr><tr><td colspan="2">source</td></tr><tr><td>Primary Care</td><td>231 (88.8 %)</td></tr><tr><td>Respirologist</td><td>7 (2.7 %)</td></tr><tr><td>Allergist</td><td>2 (0.8 %)</td></tr><tr><td>Other</td><td>10 (3.8 %)</td></tr><tr><td>Unknown</td><td>10 (3.8... |
55d8537a94af878f6318e175994e7b9734778eecc8c4f37a1c858f8c589855dc.png | simple | <table><tr><td>Absorbed dose to the thyroid (Gy)</td><td>Number of differentially expressed transcripts</td><td>Number of up- and down-regulated transcripts</td></tr><tr><td>0.05</td><td>1,225</td><td>↑ 338</td></tr><tr><td> </td><td> </td><td>↓ 887</td></tr><tr><td>0.5</td><td>1,636</td><td>↑ 480</td... | <table><tr><td>Absorbed dose to the thyroid (Gy)</td><td>Number of differentially expressed transcripts</td><td>Number of up- and down-regulated transcripts</td></tr><tr><td>0.05</td><td>1,225</td><td>↑ 338</td></tr><tr><td></td><td></td><td>↓ 887</td></tr></table> | <table><tr><td>0.5</td><td>1,636</td><td>↑ 480</td></tr><tr><td></td><td></td><td>↓ 1,156</td></tr><tr><td>1.4</td><td>544</td><td>↑ 284</td></tr><tr><td></td><td></td><td>↓ 260</td></tr><tr><td>11</td><td>575</td><td>↑ 412</td></tr><tr><td></td><td></td><td>↓ 163</td></tr><tr><td>32</td><td>425</td><td>↑ 293</td></tr>... |
6edac71a5201b32e5fac678b9230c4f3affb8c418623ede273e286fb095ade53.png | simple | <table><tr><td>Sample</td><td>shell</td><td><i>N</i></td><td><i>R</i>(Å)</td><td>σ2(×10<sup>-3</sup> Å2)</td><td>Δ<i>E</i><sub>0</sub>(eV)</td></tr><tr><td>Standard ZnS</td><td>Zn-S</td><td>4</td><td>2.35 ± 0.02</td><td>4.6 ± 0.3</td><td>4.6</td></tr><tr><td> </td><td>Zn-S-Zn</td><t... | <table><tr><td>Sample</td><td>shell</td><td>N</td><td>R(Å)</td><td>σ2(×10-3 Å2)</td><td>ΔE0(eV)</td></tr><tr><td>Standard ZnS</td><td>Zn-S</td><td>4</td><td>2.35 ± 0.02</td><td>4.6 ± 0.3</td><td>4.6</td></tr><tr><td></td><td>Zn-S-Zn</td><td>12</td><td>3.85 ± 0.02</td><td>15.3 ± 0.9</td><td>5.1</td></tr><tr><td></td><... | <table><tr><td></td><td>Zn-S-Zn</td><td>4.5</td><td>3.84 ± 0.04</td><td>15.9 ± 3.3</td><td>5.1</td></tr><tr><td></td><td>Zn-S</td><td>3</td><td>4.51 ± 0.10</td><td>15.5 ± 9.6</td><td>8.5</td></tr><tr><td>PCMS-2.5</td><td>Zn-S</td><td>4</td><td>2.34 ± 0.02</td><td>5.4 ± 0.6</td><td>4.6</td></tr><tr><td></td><td>Zn-S-Zn<... |
682d3fdd7e67b72f190559da8297c52140ec947c6b86cf9ca2a8bcecea8ec291.png | simple | <table><tr><td></td><td>N (%)</td></tr><tr><td>Lesion location</td><td></td></tr><tr><td>Right upper lobe</td><td>40/68 (58.8)</td></tr><tr><td>Right middle lobe</td><td>21/68 (30.9)</td></tr><tr><td>Right lower lobe</td><td>22/68 (32.4)</td></tr><tr><td>Left upper lobe</td><td>33/68 (48.5)</td></tr><tr><td>Left lower ... | <table><tr><td></td><td>N (%)</td></tr><tr><td>Lesion location</td><td></td></tr></table> | <table><tr><td></td><td>N (%)</td></tr><tr><td>Right upper lobe</td><td>40/68 (58.8)</td></tr><tr><td>Right middle lobe</td><td>21/68 (30.9)</td></tr><tr><td>Right lower lobe</td><td>22/68 (32.4)</td></tr><tr><td>Left upper lobe</td><td>33/68 (48.5)</td></tr><tr><td>Left lower lobe</td><td>21/68 (30.9)</td></tr><tr><td... |
c0b74e64e498ac2b0bd0edb932c9a8a20bef1a3e1e2a8aaad27de11f4280d346.png | simple | <table><tr><td>Element</td><td>Al<sub>2</sub>O<sub>3</sub></td><td>CaO</td><td>Fe<sub>2</sub>O<sub>3</sub></td><td>K<sub>2</sub>O</td><td>MgO</td><td>SO<sub>3</sub></td><td>SiO<sub>2</sub></td><td>TiO<sub>2</sub></td><td>LOI</td></tr><tr><td>SO1</td><td>3,94</td><td>70,20</td><td>0,19</td><td>0,18</td><td>0,25</td><td>... | <table><tr><td>Element</td><td>Al2O3</td><td>CaO</td><td>Fe2O3</td><td>K2O</td><td>MgO</td><td>SO3</td><td>SiO2</td><td>TiO2</td><td>LOI</td></tr><tr><td>SO1</td><td>3,94</td><td>70,20</td><td>0,19</td><td>0,18</td><td>0,25</td><td>0,00</td><td>23,36</td><td>0,10</td><td>0,40</td></tr><tr><td>SO2</td><td>3,66</td><td>7... | <table><tr><td>SO3</td><td>3,95</td><td>70,56</td><td>0,17</td><td>0,18</td><td>0,89</td><td>0,10</td><td>23,75</td><td>0,09</td><td>0,33</td></tr><tr><td>SO4</td><td>3,83</td><td>69,85</td><td>0,25</td><td>0,16</td><td>0,25</td><td>0,04</td><td>24,39</td><td>0,13</td><td>0,41</td></tr><tr><td>SO5</td><td>3,95</td><td>... |
dda81ccdd4b2311d9cb3a1c9ee2704bff7c04f607884a52879f2240b3c91d417.png | simple | <table><tr><td>Frequency</td><td>Sensitivity</td><td>Specificity</td></tr><tr><td>≥0.05</td><td>99.17% (SNV 99.30%; indel 96.60%)</td><td>>99.5%</td></tr><tr><td>≥0.10</td><td>99.66% (SNV 99.76%; indel 97.67%)</td><td>>99.5%</td></tr><tr><td>>0.20</td><td>99.70% (SNV 99.80%; indel 96.40%)</td><td>&... | <table><tr><td>Frequency</td><td>Sensitivity</td><td>Specificity</td></tr><tr><td>≥0.05</td><td>99.17% (SNV 99.30%; indel 96.60%)</td><td>>99.5%</td></tr><tr><td>≥0.10</td><td>99.66% (SNV 99.76%; indel 97.67%)</td><td>>99.5%</td></tr></table> | <table><tr><td>Frequency</td><td>Sensitivity</td><td>Specificity</td></tr><tr><td>>0.20</td><td>99.70% (SNV 99.80%; indel 96.40%)</td><td>>99.5%</td></tr></table> |
2cc8613c474d4b6cca16411d66e192940de6c5bcf08a54c43a611fb3f802ec27.png | complex | <table><tr><td> </td><td>Normal</td><td>Borderline</td><td>Case</td></tr><tr><td colspan="3">Anxiety</td><td> </td></tr><tr><td>Baseline (n=37)</td><td>28</td><td>6</td><td>3</td></tr><tr><td>3 months (n=37)</td><td>30</td><td>5</td><td>2</td></tr><tr><td>6 months (n=28)</td><td>20</td><td>6</td><td>1</td></tr><tr><td ... | <table><tr><td></td><td>Normal</td><td>Borderline</td><td>Case</td></tr><tr><td colspan="3">Anxiety</td><td></td></tr><tr><td>Baseline (n=37)</td><td>28</td><td>6</td><td>3</td></tr></table> | <table><tr><td></td><td>Normal</td><td>Borderline</td><td>Case</td></tr><tr><td>3 months (n=37)</td><td>30</td><td>5</td><td>2</td></tr><tr><td>6 months (n=28)</td><td>20</td><td>6</td><td>1</td></tr><tr><td colspan="3">Depression</td><td></td></tr><tr><td>Baseline (n=37)</td><td>31</td><td>4</td><td>2</td></tr><tr><td... |
e51f000c614b2e9343aa4b6dd07ab5a052f9dc8dca5b8b59d7e13ed88e6c88af.png | simple | <table><tr><td>Variants</td><td><i>P</i>-value</td></tr><tr><td>Age at diagnosis</td><td>0.249</td></tr><tr><td>Gender</td><td>0.543</td></tr><tr><td>WBC at diagnosis</td><td>0.533</td></tr><tr><td>Bone marrow blasts</td><td>0.733</td></tr><tr><td>Peripheral blasts</td><td>0.406</td></tr><tr><td>FLT3-ITD positive</td><... | <table><tr><td>Variants</td><td>P-value</td></tr><tr><td>Age at diagnosis</td><td>0.249</td></tr><tr><td>Gender</td><td>0.543</td></tr><tr><td>WBC at diagnosis</td><td>0.533</td></tr></table> | <table><tr><td>Bone marrow blasts</td><td>0.733</td></tr><tr><td>Peripheral blasts</td><td>0.406</td></tr><tr><td>FLT3-ITD positive</td><td>0.153</td></tr><tr><td>NPM1 mutation</td><td>0.031</td></tr><tr><td>CEBPA mutation</td><td>0.050</td></tr></table> |
3b60cbf1d0f9334473d2dc950f62396dfa089b3a42cae74fa89804b86a1d14b5.png | simple | <table><tr><td>Coefficients</td><td>Estimate</td><td>Std. Error</td><td>t Value</td></tr><tr><td>(Intercept)</td><td>−1.222e + 02</td><td>1.251e + 02</td><td>−0.977</td></tr><tr><td>SWB</td><td>−4.421e − 03</td><td>4.916e − 02</td><td>−0.090</td></tr><tr><td>SDI</td><td>9.152e −... | <table><tr><td>Coefficients</td><td>Estimate</td><td>Std. Error</td><td>t Value</td></tr><tr><td>(Intercept)</td><td>−1.222e + 02</td><td>1.251e + 02</td><td>−0.977</td></tr><tr><td>SWB</td><td>−4.421e − 03</td><td>4.916e − 02</td><td>−0.090</td></tr><tr><td>SDI</td><td>9.152e − 02</td><td>5.400e − 02</td><td>1.695</td... | <table><tr><td>Non-Hispanic White or Euro-American</td><td>2.627e + 00</td><td>1.295e + 00</td><td>2.028</td></tr><tr><td>Latino or Hispanic American</td><td>8.577e + 00</td><td>2.872e + 00</td><td>2.987</td></tr><tr><td>Other/Multi-Racial</td><td>−5.138e + 00</td><td>3.248e + 00</td><td>−1.582</td></tr></table> |
4dbbf37667dfc589cf62ab6a53de7db34126404d5577dda9c77bd48d6dc34cda.png | complex | <table><tr><td rowspan="2">Concentration μg/mL</td><td colspan="7">Viability (%)/compound</td></tr><tr><td>9</td><td>10</td><td>11a</td><td>11b</td><td>12</td><td>13</td><td>14</td></tr><tr><td>500</td><td>8.43</td><td>8.32</td><td>23.84</td><td>10.32</td><td>4.29</td><td>4.83</td><td>3.74</td></tr><tr><td>250</td... | <table><tr><td rowspan="2">Concentration μg/mL</td><td colspan="3">Viability (%)/compound</td></tr><tr><td>9</td><td>10</td><td>11a</td></tr><tr><td>500</td><td>8.43</td><td>8.32</td><td>23.84</td></tr><tr><td>250</td><td>15.82</td><td>16.01</td><td>48.67</td></tr><tr><td>125</td><td>24.67</td><td>23.65</td><td>72.89</... | <table><tr><td colspan="4">Viability (%)/compound</td></tr><tr><td>11b</td><td>12</td><td>13</td><td>14</td></tr><tr><td>10.32</td><td>4.29</td><td>4.83</td><td>3.74</td></tr><tr><td>19.47</td><td>11.82</td><td>12.56</td><td>8.91</td></tr><tr><td>27.93</td><td>20.49</td><td>19.74</td><td>14.82</td></tr><tr><td>38.76</t... |
1d9c41e505253dd66c038d78bbd116b85e397c65fa21062556caf369cb030417.png | simple | <table><tr><td>Organism</td><td>HIV seropositive cases(<i>n</i> = 144)</td><td>HIV seronegative subjects(<i>n</i> = 50)</td><td><i>P</i> value (chi-square test)</td></tr><tr><td><i>C. parvum </i></td><td>87 (60.42%)</td><td>1 (2.00%)</td><td>0.0001</td></tr><tr><td><i>I. belli </i></td><td>13 (9.03%)</td><td>1 (2.00%)<... | <table><tr><td>Organism</td><td>HIV seropositive cases(n = 144)</td><td>HIV seronegative subjects(n = 50)</td><td>P value (chi-square test)</td></tr><tr><td>C. parvum</td><td>87 (60.42%)</td><td>1 (2.00%)</td><td>0.0001</td></tr><tr><td>I. belli</td><td>13 (9.03%)</td><td>1 (2.00%)</td><td>0.082</td></tr><tr><td>Cyclos... | <table><tr><td>Microsporidium spp.</td><td>1 (0.69%)</td><td>0</td><td>—</td></tr><tr><td>E. histolytica</td><td>7 (4.86%)</td><td>1 (2.00%)</td><td>0.343</td></tr><tr><td>G. lamblia</td><td>3 (2.08%)</td><td>2 (4.00%)</td><td>0.726</td></tr><tr><td>A. lumbricoides</td><td>5 (3.47%)</td><td>1 (2.00%)</td><td>0.514*</td... |
35f572f882e832bf65dd28e354167165fa6746d076dc1cd5a3335035e130e2c9.png | complex | <table><tr><td></td><td colspan="3">Univariate Analysis</td><td colspan="3">Multivariate Analysis</td></tr><tr><td>Variable</td><td>Hazard ratio</td><td>95% C.I.</td><td>P</td><td>Hazard ratio</td><td>95% C.I.</td><td>P</td></tr><tr><td>Age, years (continuous)</td><td>1.01</td><td>0.96-1.06</td><td>0.78</td><td>-</td><... | <table><tr><td></td><td colspan="3">Univariate Analysis</td><td colspan="3">Multivariate Analysis</td></tr><tr><td>Variable</td><td>Hazard ratio</td><td>95% C.I.</td><td>P</td><td>Hazard ratio</td><td>95% C.I.</td><td>P</td></tr><tr><td>Age, years (continuous)</td><td>1.01</td><td>0.96-1.06</td><td>0.78</td><td>-</td><... | <table><tr><td></td><td colspan="3">Univariate Analysis</td><td colspan="3">Multivariate Analysis</td></tr><tr><td>CD68+ TIM</td><td>0.96</td><td>0.29-3.16</td><td>0.95</td><td></td><td></td><td></td></tr><tr><td>FoxP3+ TIL</td><td>0.58</td><td>0.17-1.99</td><td>0.39</td><td></td><td></td><td></td></tr><tr><td>Granzyme... |
6b63dfe953e9742525e8c26f3e5ee6aba0363e20b9733df61d3f65336c569232.png | complex | <table><tr><td></td><td></td><td colspan="2">Patient A</td><td colspan="2">Patient B</td><td colspan="2">Patient C</td><td colspan="2">Patient D</td><td colspan="2">Patient E</td></tr><tr><td rowspan="3">Parameters obtained from data</td><td>Hb (g dl<sup>−1</sup>)</td><td colspan="2">10.5</td><td colspan="2">10.8... | <table><tr><td></td><td></td><td colspan="2">Patient A</td></tr><tr><td rowspan="3">Parameters obtained from data</td><td>Hb (g dl−1)</td><td colspan="2">10.5</td></tr><tr><td>CO (l min−1)</td><td colspan="2">11.1</td></tr><tr><td>FIO2</td><td colspan="2">0.8</td></tr><tr><td rowspan="4">Parameters obtained through opt... | <table><tr><td colspan="2">Patient B</td><td colspan="2">Patient C</td><td colspan="2">Patient D</td><td colspan="2">Patient E</td></tr><tr><td colspan="2">10.8</td><td colspan="2">11.5</td><td colspan="2">9.8</td><td colspan="2">9</td></tr><tr><td colspan="2">7.2</td><td colspan="2">5.6</td><td colspan="2">7.7</td><td... |
0260dbeb9753d094a5f6a5200ad522457b598b33fd6e5db6fb0cf371ef46e5e7.png | complex | <table><tr><td></td><td>Non-nosocomial (<i>n</i> = 352)</td><td>Nosocomial (<i>n</i> = 25)</td><td><i>P</i> value</td></tr><tr><td>Median week from admission</td><td></td><td>3 (2–4)</td><td></td></tr><tr><td>Male (%)</td><td>65·9 (230/349)</td><td>60·0 (15/25)</td><td>0·664</td></tr><tr><td>Age (w... | <table><tr><td></td><td>Non-nosocomial (n = 352)</td><td>Nosocomial (n = 25)</td><td>P value</td></tr><tr><td>Median week from admission</td><td></td><td>3 (2–4)</td><td></td></tr><tr><td>Male (%)</td><td>65·9 (230/349)</td><td>60·0 (15/25)</td><td>0·664</td></tr><tr><td>Age (weeks, median)</td><td>16·2 (8·8–43·5)</td>... | <table><tr><td>Leukocytes (×1000/μl)</td><td>14·0 (10·7–17·1)</td><td>13·0 (9·6–16·4)</td><td>0·313</td></tr><tr><td>Neutrophils (%)</td><td>49·5 (31·9–61·2)</td><td>32·0 (26·0–44·8)</td><td>0·001</td></tr><tr><td>Lymphocytes (%)</td><td>39·7 (28·1–56·1)</td><td>53·7 (45·7–65·2)</td><td>0·002</td></tr><tr><td>Platelets... |
effa74d300286437f14c815db8392b3b9602440497d209cf539f60ea412956a6.png | simple | <table><tr><td></td><td>Recall</td><td>Precision</td><td>F-score</td></tr><tr><td>Any</td><td>79.46</td><td>78.45</td><td>78.95</td></tr><tr><td>Unrelated</td><td>60.26</td><td>70.59</td><td>65.02</td></tr><tr><td>Altered expression</td><td>77.96</td><td>79.90</td><td>78.91</td></tr><tr><td>Genetic variation</td><td>77... | <table><tr><td></td><td>Recall</td><td>Precision</td><td>F-score</td></tr></table> | <table><tr><td>Any</td><td>79.46</td><td>78.45</td><td>78.95</td></tr><tr><td>Unrelated</td><td>60.26</td><td>70.59</td><td>65.02</td></tr><tr><td>Altered expression</td><td>77.96</td><td>79.90</td><td>78.91</td></tr><tr><td>Genetic variation</td><td>77.76</td><td>82.45</td><td>80.04</td></tr><tr><td>Regulatory modific... |
776a0d2f5055cd13a68598ecb58c4c364b3440f8e5fcafaee2e5e01783c11e3a.png | simple | <table><tr><td></td><td>All patients</td><td>PiCCO</td><td>PAC</td><td><i>p </i>value</td></tr><tr><td>Mean daily FB (ml/day)</td><td>490 (-216, 1,259)</td><td>659 (-128, 1,403)</td><td>350 (-573, 1,064)</td><td>0.017</td></tr><tr><td>MV days</td><td>5 (2, 10)</td><td>6 (2, 10)</td><td>4 (2, 10)</td><td>0.44</td></tr><... | <table><tr><td></td><td>All patients</td><td>PiCCO</td><td>PAC</td><td>p value</td></tr><tr><td>Mean daily FB (ml/day)</td><td>490 (-216, 1,259)</td><td>659 (-128, 1,403)</td><td>350 (-573, 1,064)</td><td>0.017</td></tr><tr><td>MV days</td><td>5 (2, 10)</td><td>6 (2, 10)</td><td>4 (2, 10)</td><td>0.44</td></tr><tr><td>... | <table><tr><td></td><td>All patients</td><td>PiCCO</td><td>PAC</td><td>p value</td></tr><tr><td>ICU mortality</td><td>34.7%</td><td>38.5%</td><td>30.0%</td><td>0.11</td></tr><tr><td>Hospital mortality</td><td>42.0%</td><td>45.8%</td><td>36.9%</td><td>0.12</td></tr></table> |
d17693f5b63285c2d029177b7e4ab6e4dbc2db21cb11e69eea92d63719c5cc38.png | complex | <table><tr><td></td><td>Elderly patients</td><td>Non-elderly patients</td><td><i>p</i> value</td></tr><tr><td>Patients (<i>n</i>)</td><td>157 (32.6%)</td><td>325 (67.4%)</td><td rowspan="2"></td></tr><tr><td>Age (years), mean (range)</td><td>79.3 (75–90)</td><td>63.9 (27–74)</td></tr><tr><td>Sex, male/femal... | <table><tr><td></td><td>Elderly patients</td><td>Non-elderly patients</td><td>p value</td></tr><tr><td>Patients (n)</td><td>157 (32.6%)</td><td>325 (67.4%)</td><td rowspan="2"></td></tr><tr><td>Age (years), mean (range)</td><td>79.3 (75–90)</td><td>63.9 (27–74)</td></tr><tr><td>Sex, male/female</td><td>92/65</td><td>19... | <table><tr><td>Depressed</td><td>0 (0.0%)</td><td>2 (0.6%)</td><td rowspan="2">0.68</td></tr><tr><td>Residual/local recurrence</td><td>2 (1.2%)</td><td>6 (1.8%)</td></tr><tr><td colspan="4">Histological classification (n)</td></tr><tr><td>Adenoma</td><td>52 (31.7%)</td><td>131 (38.9%)</td><td rowspan="6">0.47</td></tr>... |
6984b125096c3471dbe7fe5e1db0cc9f6cb6c01f62414edd945f2d466935000e.png | complex | <table><tr><td>Key words</td><td colspan="2">Other variations of key words</td></tr><tr><td rowspan="4">NCDs metabolic risk factors plus proximal determinants plus distal determinants plus geographic location</td><td>NCDs metabolic risk factors</td><td>High blood pressure, hypertension, high blood glucose, hyperglycemi... | <table><tr><td>Key words</td><td colspan="2">Other variations of key words</td></tr><tr><td rowspan="4">NCDs metabolic</td><td>NCDs metabolic risk factors</td><td>High blood pressure, hypertension, high blood glucose, hyperglycemia, diabetes, high BMI, obesity, overweight, waist circumference, waist-hip ratio</td></tr>... | <table><tr><td>Key words</td><td colspan="2">Other variations of key words</td></tr><tr><td> risk factors plus proximal determinants plus distal determinants plus geographic location</td><td>ia</td><td>dives, Afghanistan</td></tr></table> |
c822e02027766c9a69de359b08f842db7c34639a22958d433ae5025f50279c24.png | complex | <table><tr><td rowspan="2">Characteristics</td><td rowspan="2"></td><td rowspan="2">Prevalence (%) of PN (n = 300)</td><td colspan="2">Univariate models</td><td colspan="2">Multivariate models</td></tr><tr><td>Odds ratio (OR) (95% CI)</td><td>p-value</td><td>Adjusted odds ratio (aOR) (95% CI)</td><td><i>p-value</i></td... | <table><tr><td rowspan="2">Characteristics</td><td rowspan="2"></td><td rowspan="2">Prevalence (%) of PN (n = 300)</td><td colspan="2">Univariate models</td><td colspan="2">Multivariate models</td></tr><tr><td>Odds ratio (OR) (95% CI)</td><td>p-value</td><td>Adjusted odds ratio (aOR) (95% CI)</td><td>p-value</td></tr><... | <table><tr><td rowspan="2"></td><td rowspan="2">Prevalence (%) of PN (n = 300)</td><td colspan="2">Univariate models</td></tr><tr><td>Odds ratio (OR) (95% CI)</td><td>p-value</td></tr><tr><td>D4T containing</td><td>196 (57)</td><td>0.8 (0.6, 1.2)</td><td>0.27</td></tr></table> |
0c50810904a48069bca9570356c51407651867318254219e721e5c25ebca5481.png | simple | <table><tr><td></td><td>Training set</td><td>Development set</td><td>Test set</td><td>Entire corpus</td></tr><tr><td>Abstracts</td><td>3,500</td><td>3,500</td><td>3,000</td><td>10,000</td></tr><tr><td>Nr. characters</td><td>4,883,753</td><td>4,864,558</td><td>4,199,068</td><td>13,947,379</td></tr><tr><td>Nr. tokens</td... | <table><tr><td></td><td>Training set</td></tr><tr><td>Abstracts</td><td>3,500</td></tr><tr><td>Nr. characters</td><td>4,883,753</td></tr><tr><td>Nr. tokens</td><td>770,855</td></tr><tr><td>Abstracts with SACEM</td><td>2,916</td></tr><tr><td>Nr. mentions</td><td>29,478</td></tr><tr><td>Nr. chemicals</td><td>8,520</td></... | <table><tr><td>Development set</td><td>Test set</td><td>Entire corpus</td></tr><tr><td>3,500</td><td>3,000</td><td>10,000</td></tr><tr><td>4,864,558</td><td>4,199,068</td><td>13,947,379</td></tr><tr><td>766,331</td><td>662,571</td><td>2,199,757</td></tr><tr><td>2,907</td><td>2,478</td><td>8,301</td></tr><tr><td>29,526<... |
ede4ddb46849ddc5d5528053e7b91597ba2045f16b198c5e0b815c1d2b4d3b08.png | simple | <table><tr><td></td><td>FeNO</td><td>CalvNO</td><td>nNO</td></tr><tr><td>Asthma</td><td>Normal/increased</td><td>Normal/increased</td><td>Normal/increased</td></tr><tr><td>COPD</td><td>Normal/increased</td><td>Increased</td><td>NS</td></tr><tr><td>CF</td><td>Normal/decreased</td><td>Contradictory results</td><td>Decrea... | <table><tr><td></td><td>FeNO</td><td>CalvNO</td></tr><tr><td>Asthma</td><td>Normal/increased</td><td>Normal/increased</td></tr><tr><td>COPD</td><td>Normal/increased</td><td>Increased</td></tr><tr><td>CF</td><td>Normal/decreased</td><td>Contradictory results</td></tr><tr><td>PCD</td><td>Normal/decreased</td><td>Contradi... | <table><tr><td>nNO</td></tr><tr><td>Normal/increased</td></tr><tr><td>NS</td></tr><tr><td>Decreased</td></tr><tr><td>Decreased</td></tr><tr><td>NS</td></tr><tr><td>NS</td></tr><tr><td>NS</td></tr><tr><td>NS</td></tr><tr><td>NS</td></tr><tr><td>NS</td></tr><tr><td>NS</td></tr></table> |
453735c26a8f3649441d0d766db325d1919ec6a788e1a33ee2cdcb990dfd2397.png | complex | <table><tr><td>Allele</td><td>DYS635</td><td>DYS456</td><td>DYS458</td><td>DYS391</td><td>DYS392</td><td>DYS390</td><td>DYS393</td><td>DYS438</td><td colspan="4">DYS385a,b</td></tr><tr><td>8</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>0.0185</td><td>10,12</td><td>0.0093</td><td>13,17</td><td>... | <table><tr><td>Allele</td><td>DYS635</td><td>DYS456</td><td>DYS458</td><td>DYS391</td><td>DYS392</td><td>DYS390</td><td>DYS393</td><td>DYS438</td><td colspan="4">DYS385a,b</td></tr><tr><td>8</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>0.0185</td><td>10,12</td><td>0.0093</td><td>13,17</td><td>... | <table><tr><td>17</td><td></td><td>0.0741</td><td>0.2778</td><td></td><td></td><td></td><td></td><td></td><td>12,14</td><td>0.0093</td><td>14,22</td><td>0.0093</td></tr><tr><td>18</td><td></td><td>0.0093</td><td>0.2222</td><td></td><td></td><td></td><td></td><td></td><td>12,15</td><td>0.0093</td><td>15,17</td><td>0.009... |
44e17eafc38342674247b22a1cbd8a5a9d5811ff48e25342155a4c34add9fd8f.png | simple | <table><tr><td>KEGGID</td><td>Pvalue</td><td>Count</td><td>Size</td><td>Term</td></tr><tr><td>4530</td><td>0.011</td><td>3</td><td>11</td><td>Tight junction</td></tr><tr><td>533</td><td>0.046</td><td>1</td><td>1</td><td>Keratan sulfate biosynthesis</td></tr><tr><td>604</td><td>0.046</td><td>1</td><td>1</td><td>Glycosph... | <table><tr><td>KEGGID</td><td>Pvalue</td><td>Count</td><td>Size</td><td>Term</td></tr><tr><td>4530</td><td>0.011</td><td>3</td><td>11</td><td>Tight junction</td></tr><tr><td>533</td><td>0.046</td><td>1</td><td>1</td><td>Keratan sulfate biosynthesis</td></tr><tr><td>604</td><td>0.046</td><td>1</td><td>1</td><td>Glycosph... | <table><tr><td>KEGGID</td><td>Pvalue</td><td>Count</td><td>Size</td><td>Term</td></tr><tr><td>51</td><td>0.059</td><td>2</td><td>9</td><td>Fructose and mannose metabolism</td></tr><tr><td>4210</td><td>0.059</td><td>2</td><td>9</td><td>Apoptosis</td></tr><tr><td>3010</td><td>0.064</td><td>3</td><td>21</td><td>Ribosome</... |
6a1180aace651fe262d7315b71493bd21560d195fc7c639626799951fd99f9cc.png | simple | <table><tr><td>Gene</td><td>Abbreviation</td><td>Teleost accession number</td><td>Transcript in the greater amberjack</td><td><i>In silico</i> group</td><td>DE* male vs female gonads</td><td>Sex determining in</td></tr><tr><td>DM domain gene on the Y chromosome/ doublesex and mab-3-related transcription factor 1a</td><... | <table><tr><td>Gene</td><td>Abbreviation</td><td>Teleost accession number</td><td>Transcript in the greater amberjack</td><td>In silico group</td><td>DE* male vs female gonads</td><td>Sex determining in</td></tr><tr><td>DM domain gene on the Y chromosome/ doublesex and mab-3-related transcription factor 1a</td><td>dmY/... | <table><tr><td>Gene</td><td>Abbreviation</td><td>Teleost accession number</td><td>Transcript in the greater amberjack</td><td>In silico group</td><td>DE* male vs female gonads</td><td>Sex determining in</td></tr><tr><td>Gonadal soma-derived factor</td><td>gsdf</td><td>Oryzias latipes NM_0 011 77742 chr.12</td><td>Augus... |
f96f7f206c451227aed44e2c39f8adab4acc519320324a80295677390bf0270d.png | simple | <table><tr><td>Number of women (percentage)</td><td>357</td><td>(92%)</td></tr><tr><td>Median years of age (IQR)</td><td>52</td><td>(8)</td></tr><tr><td>Median years of age diagnosed with a pain disorder (IQR)<sup>a</sup></td><td>30</td><td>(18)</td></tr><tr><td>Median PPI (IQR)</td><td>4</td><td>(3)</td></tr><tr><td>M... | <table><tr><td>Number of women (percentage)</td><td>357</td><td>(92%)</td></tr><tr><td>Median years of age (IQR)</td><td>52</td><td>(8)</td></tr><tr><td>Median years of age diagnosed with a pain disorder (IQR)a</td><td>30</td><td>(18)</td></tr><tr><td>Median PPI (IQR)</td><td>4</td><td>(3)</td></tr><tr><td>Median numbe... | <table><tr><td>Median number of past pain medications (IQR)</td><td>6</td><td>(7)</td></tr></table> |
8bb7e0431fba6a985b82ea94e8368c176aaa376913e6c5c6f0810408bb83c00e.png | complex | <table><tr><td colspan="2"></td><td>Nurses</td><td><i>Controls</i></td></tr><tr><td colspan="2"><i>N</i></td><td>32</td><td>30</td></tr><tr><td colspan="2">Age (in years)</td><td>40.3 (11.3)</td><td>40.0 (12.3)</td></tr><tr><td colspan="2">Sex (male/female)</td><td>7/25</td><td>3/27</td></tr><tr><td rowspan="4">Educati... | <table><tr><td colspan="2"></td><td>Nurses</td><td>Controls</td></tr><tr><td colspan="2">N</td><td>32</td><td>30</td></tr><tr><td colspan="2">Age (in years)</td><td>40.3 (11.3)</td><td>40.0 (12.3)</td></tr><tr><td colspan="2">Sex (male/female)</td><td>7/25</td><td>3/27</td></tr><tr><td>Education</td><td>lower secondary... | <table><tr><td rowspan="3">Education</td><td>Intermediate secondary school (Realschule)</td><td>18</td><td>22</td></tr><tr><td>Higher education entrance qualification (Abitur) (finished or enrolled)</td><td>5</td><td>4</td></tr><tr><td>University degree</td><td>2</td><td>0</td></tr></table> |
b2e3c3737cb1e5c9aad731f6cb82e8d5f195e477ba9fd234fd43895e518c6e0c.png | complex | <table><tr><td>Dependent variable</td><td>Fivefolded cross-validated <i>R</i><sup>2</sup> (%)</td><td>Effect size, <i>f</i><sup>2</sup></td></tr><tr><td colspan="3">MUSICIANS ONLY</td></tr><tr><td>Judgment line orientation</td><td>15</td><td>0.18</td></tr><tr><td>Letter-number sequencing</td><td>14</td><td>0.16</td></t... | <table><tr><td>Dependent variable</td><td>Fivefolded cross-validated R2 (%)</td></tr><tr><td colspan="2">MUSICIANS ONLY</td></tr><tr><td>Judgment line orientation</td><td>15</td></tr><tr><td>Letter-number sequencing</td><td>14</td></tr><tr><td>Tower rule violations</td><td>0</td></tr><tr><td>Letter fluency</td><td>0</t... | <table><tr><td>Effect size, f2</td></tr><tr><td>MUSICIANS ONLY</td></tr><tr><td>0.18</td></tr><tr><td>0.16</td></tr><tr><td>0.00</td></tr><tr><td>0.00</td></tr><tr><td>0.00</td></tr><tr><td>0.21</td></tr><tr><td>0.20</td></tr></table> |
cfa2a42d3db864c4cf6125b70ddfa24cc382bbc6362dbfff34ca6e3c3f268e3b.png | simple | <table><tr><td><i>PT number</i></td><td><i>Global</i></td><td><i>For strengthening exercises</i></td><td><i>For stretching exercises</i></td></tr><tr><td>1</td><td>0.74 (0.58–0.84)</td><td>0.68 (0.38–0.84)</td><td>0.78 (0.57–0.91)</td></tr><tr><td>2</td><td>0.72 (0.57–0.81)</td><td>0.71 (0.43... | <table><tr><td>PT number</td><td>Global</td><td>For strengthening exercises</td><td>For stretching exercises</td></tr><tr><td>1</td><td>0.74 (0.58–0.84)</td><td>0.68 (0.38–0.84)</td><td>0.78 (0.57–0.91)</td></tr><tr><td>2</td><td>0.72 (0.57–0.81)</td><td>0.71 (0.43–0.84)</td><td>0.68 (0.46–0.81)</td></tr><tr><td>3</td>... | <table><tr><td>PT number</td><td>Global</td><td>For strengthening exercises</td><td>For stretching exercises</td></tr><tr><td>4</td><td>0.82 (0.73–0.89)</td><td>0.81 (0.71–0.87)</td><td>0.84 (0.67–0.96)</td></tr><tr><td>5</td><td>0.86 (0.73–0.93)</td><td>0.82 (0.48–0.94)</td><td>0.88 (0.73–0.94)</td></tr><tr><td>6</td>... |
d606f259ff0430c4bcf11d03763ec8dd72523e39ba8a0e9c0f1637ed01e6c8e7.png | complex | <table><tr><td colspan="6">Year</td></tr><tr><td>Variable</td><td>2010</td><td>2011</td><td>2012</td><td>2013</td><td>Total</td></tr><tr><td></td><td>N (%)</td><td>N (%)</td><td>N (%)</td><td>N (%)</td><td>N (%)</td></tr><tr><td colspan="6">Sex</td></tr><tr><td> Female</td><td>41(45)</td><td>26(50)</td><td>83(36.4)</td... | <table><tr><td colspan="6">Year</td></tr><tr><td>Variable</td><td>2010</td><td>2011</td><td>2012</td><td>2013</td><td>Total</td></tr><tr><td></td><td>N (%)</td><td>N (%)</td><td>N (%)</td><td>N (%)</td><td>N (%)</td></tr><tr><td colspan="6">Sex</td></tr><tr><td>Female</td><td>41(45)</td><td>26(50)</td><td>83(36.4)</td>... | <table><tr><td colspan="6">Year</td></tr><tr><td>Variable</td><td>2010</td><td>2011</td><td>2012</td><td>2013</td><td>Total</td></tr><tr><td></td><td>N (%)</td><td>N (%)</td><td>N (%)</td><td>N (%)</td><td>N (%)</td></tr><tr><td>Total</td><td>91(100)</td><td>52(100)</td><td>228(100)</td><td>313(100)</td><td>684(100)</t... |
cd925464015c3077e8bd93508331b389f58460d1d1d61f8893445bf734178eb8.png | complex | <table><tr><td>Welding Positions</td><td>No. of Butt Welds</td><td>Laser Beam Power, W</td><td>Traveling Speed, m/min</td><td>Heat Input, kJ/m</td></tr><tr><td rowspan="2">Vertical up</td><td>U01</td><td>2200</td><td>0.5</td><td>275</td></tr><tr><td>U02</td><td>2500</td><td>1.2</td><td>125</td></tr><tr><td rowspan="2">... | <table><tr><td>Welding Positio</td><td>No.</td><td></td><td>Traveling S</td><td>Heat</td></tr></table> | <table><tr><td>ns</td><td> of Butt Welds</td><td>Laser Beam Power, W</td><td>peed, m/min</td><td> Input, kJ/m</td></tr><tr><td rowspan="2">Vertical up</td><td>U01</td><td>2200</td><td>0.5</td><td>275</td></tr><tr><td>U02</td><td>2500</td><td>1.2</td><td>125</td></tr><tr><td rowspan="2">Vertical down</td><td>D01</td><td... |
9255e6b662c60aea9a3be198f787cab0c69a04d44f529ca6c1f4d418d37f2a58.png | complex | <table><tr><td rowspan="2"></td><td rowspan="2">Organs</td><td rowspan="2"><i>n</i></td><td colspan="2">Elks up to 2 years</td><td rowspan="2"><i>n</i></td><td colspan="2">Elks older than 3 years</td></tr><tr><td>Mean ± SD</td><td>Median</td><td>Mean ± SD</td><td>Median</td></tr><tr><td rowspan="3">Cu</td><td... | <table><tr><td rowspan="2"></td><td rowspan="2">Organs</td><td rowspan="2">n</td><td colspan="2">Elks up to 2 years</td><td rowspan="2">n</td><td colspan="2">Elks older than 3 years</td></tr><tr><td>Mean ± SD</td><td>Median</td><td>Mean ± SD</td><td>Median</td></tr><tr><td rowspan="2">Cu</td><td>Liver</td><td>8</td><td... | <table><tr><td rowspan="2"></td><td rowspan="2">Organs</td><td rowspan="2">n</td><td colspan="2">Elks up to 2 years</td><td rowspan="2">n</td><td colspan="2">Elks older than 3 years</td></tr><tr><td>Mean ± SD</td><td>Median</td><td>Mean ± SD</td><td>Median</td></tr><tr><td>Cu</td><td>Muscle</td><td>8</td><td>2.68 ± 0.5... |
8e2588edfb19978c9404e488c8d35cd8a530ac51ff97e51a377ae940bdc63ec8.png | complex | <table><tr><td> </td><td colspan="6">Voyage</td></tr><tr><td> </td><td colspan="2">1</td><td colspan="2">2</td><td colspan="2">3</td></tr><tr><td>Measure</td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td></tr><tr><td>Indoor cabin temp (°C)</td><td>20.97</td><td>1.1</td><td>20.83</td><td>0... | <table><tr><td></td><td colspan="6">Voyage</td></tr><tr><td></td><td colspan="2">1</td><td colspan="2">2</td><td colspan="2">3</td></tr><tr><td>Measure</td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td></tr><tr><td>Indoor cabin temp (°C)</td><td>20.97</td><td>1.1</td><td>20.83</td><td>0.9</td>... | <table><tr><td></td><td colspan="6">Voyage</td></tr><tr><td></td><td colspan="2">1</td><td colspan="2">2</td><td colspan="2">3</td></tr><tr><td>Measure</td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td></tr><tr><td>Wind chill (°C)</td><td>1.92</td><td>5.55</td><td>3.50</td><td>3.08</td><td>2.6... |
9b369c7006e7c35eba58ada59155a685e8b7c774690b0a115fedc83c909f9427.png | simple | <table><tr><td>Category</td><td>Term</td><td>Count</td><td><i>P</i>-value</td><td>Benjamini</td></tr><tr><td>KEGG_PATHWAY</td><td>Cytokine-cytokine receptor interaction</td><td>24</td><td>9.00E-07</td><td>1.30E-04</td></tr><tr><td>GOTERM_BP_FAT</td><td>Immune response</td><td>18</td><td>1.90E-03</td><td>2.50E-01</td></... | <table><tr><td>Category</td><td>Term</td><td>Count</td><td>P-value</td><td>Benjamini</td></tr><tr><td>KEGG_PATHWAY</td><td>Cytokine-cytokine receptor interaction</td><td>24</td><td>9.00E-07</td><td>1.30E-04</td></tr><tr><td>GOTERM_BP_FAT</td><td>Immune response</td><td>18</td><td>1.90E-03</td><td>2.50E-01</td></tr><tr>... | <table><tr><td>INTERPRO</td><td>Immunoglobulin</td><td>6</td><td>4.50E-02</td><td>9.00E-01</td></tr><tr><td>KEGG_PATHWAY</td><td>Type I diabetes mellitus</td><td>6</td><td>6.90E-02</td><td>4.70E-01</td></tr><tr><td>GOTERM_BP_FAT</td><td>Behavior</td><td>6</td><td>7.90E-02</td><td>9.20E-01</td></tr><tr><td>GOTERM_BP_FAT... |
8c49f287ce51a8ab669acc75ff91dc93fa5b45fcfc816b7dfa5a50a03d472326.png | simple | <table><tr><td>Time (min)</td><td>% Eluent A (0.1% TFA in <sup>d</sup>H<sub>2</sub>O)</td><td>% Eluent B (MeOH)</td><td>Flow Rate (mL/min)</td></tr><tr><td>0</td><td>15</td><td>85</td><td>1.5</td></tr><tr><td>6</td><td>0</td><td>100</td><td>1.5</td></tr><tr><td>25</td><td>0</td><td>100</td><td>1.5</td></tr><tr><td>26</... | <table><tr><td>Time (min)</td><td>% Eluent A (0.1% TFA in dH2O)</td><td>% Eluent B (MeOH)</td><td>Flow Rate (mL/min)</td></tr><tr><td>0</td><td>15</td><td>85</td><td>1.5</td></tr><tr><td>6</td><td>0</td><td>10</td><td>1.5</td></tr></table> | <table><tr><td>Time (min)</td><td>% Eluent A (0.1% TFA in dH2O)</td><td>% Eluent B (MeOH)</td><td>Flow Rate (mL/min)</td></tr><tr><td></td><td></td><td>0</td><td></td></tr><tr><td>25</td><td>0</td><td>100</td><td>1.5</td></tr><tr><td>26</td><td>15</td><td>85</td><td>1.5</td></tr><tr><td>35</td><td>15</td><td>85</td><td... |
92defea45595628c423c6b33816e6275848fa76b18bfd7696c4018aad473cb69.png | complex | <table><tr><td rowspan="2" colspan="2">Variable</td><td colspan="2">PCS</td><td colspan="2">MCS</td><td colspan="2">KDCS</td></tr><tr><td>Score</td><td><i>p</i>-value</td><td>Score</td><td><i>p</i>-value</td><td>Score</td><td><i>p</i>-value</td></tr><tr><td rowspan="2">Age</td><td><45 years (<i>n</i> = 11)</td><td>4... | <table><tr><td rowspan="2" colspan="2">Variable</td><td colspan="2">PCS</td><td colspan="2">MCS</td><td colspan="2">KDCS</td></tr><tr><td>Score</td><td>p-value</td><td>Score</td><td>p-value</td><td>Score</td><td>p-value</td></tr><tr><td rowspan="2">Age</td><td><45 years (n = 11)</td><td>49.8</td><td rowspan="2">0.89</t... | <table><tr><td rowspan="2" colspan="2">Variable</td><td colspan="2">PCS</td><td colspan="2">MCS</td><td colspan="2">KDCS</td></tr><tr><td>Score</td><td>p-value</td><td>Score</td><td>p-value</td><td>Score</td><td>p-value</td></tr><tr><td rowspan="2">Education status</td><td>Secondary or below (n = 9)</td><td>47.1</td><t... |
390ea9d981372050d854968fabc26037ce9856819b7125772fe1863edbe6a10c.png | complex | <table><tr><td>Characteristics</td><td colspan="2">OCP-patch (<i>N</i> = 30)</td><td colspan="2">LTS-2 patch (<i>N</i> = 30)</td></tr><tr><td>Definition of reaction</td><td>At 24 h</td><td>At 30 h</td><td>At 24 h</td><td>At 30 h</td></tr><tr><td> None</td><td>3 (10.0)</td><td>2 (6.7)</td><td>5 (16.7)</td><td>0</td></tr... | <table><tr><td>Characteristics</td><td colspan="2">OCP-patch (N = 30)</td><td colspan="2">LTS-2 patch (N = 30)</td></tr><tr><td>Definition of reaction</td><td>At 24 h</td><td>At 30 h</td><td>At 24 h</td><td>At 30 h</td></tr><tr><td>None</td><td>3 (10.0)</td><td>2 (6.7)</td><td>5 (16.7)</td><td>0</td></tr><tr><td>Oedema... | <table><tr><td>Characteristics</td><td colspan="2">OCP-patch (N = 30)</td><td colspan="2">LTS-2 patch (N = 30)</td></tr><tr><td>Character of papules</td><td></td><td></td><td></td><td></td></tr><tr><td>None</td><td>3 (10.0)</td><td>2 (6.7)</td><td>5 (16.7)</td><td>0</td></tr><tr><td>Vague</td><td>4 (13.3)</td><td>1 (3.... |
ca58de56b913c3bdc689bc12cf7e44a9e639a35e4ccac9c811d414941b92a243.png | simple | <table><tr><td>Studies</td><td>Reported outcomes</td><td>Follow up period</td><td>Bias grade</td></tr><tr><td>Brar2008</td><td>Death, MI</td><td>9.7 months</td><td>-</td></tr><tr><td>I-LOVE IT 2</td><td>NACCE, death, MI, stroke, TVR, TLR, ST, all bleeding, major bleeding</td><td>12 and 18 months</td><td>B</td></tr><tr>... | <table><tr><td>Studies</td></tr><tr><td>Brar2008</td></tr><tr><td>I-LOVE IT 2</td></tr><tr><td>ISAR-SAFE</td></tr><tr><td>Tarantini2016</td></tr><tr><td>ARCTIC</td></tr><tr><td>OPTIMIZE</td></tr><tr><td>RESET</td></tr><tr><td>EXCELLENT</td></tr><tr><td>PEGASUS</td></tr><tr><td>DAPT</td></tr><tr><td>Sardella2011</td></t... | <table><tr><td>Reported outcomes</td><td>Follow up period</td><td>Bias grade</td></tr><tr><td>Death, MI</td><td>9.7 months</td><td>-</td></tr><tr><td>NACCE, death, MI, stroke, TVR, TLR, ST, all bleeding, major bleeding</td><td>12 and 18 months</td><td>B</td></tr><tr><td>Primary endpoints, death, MI, ST, stroke, TIMI ma... |
81a78c7410b3b843470adf34e5ab52d39eb292a5ccfd23d166f69fdc4a9ec2a7.png | complex | <table><tr><td>Variable</td><td colspan="2">Univariate</td><td colspan="2">Multivariate</td><td colspan="2">Covariate height</td><td colspan="2">Covariate gender</td></tr><tr><td></td><td><i>B</i> (95% CI)</td><td><i>P</i> value</td><td><i>B</i> (95% CI)</td><td><i>P</i> value</td><td><i>B</i> (95% CI)</td><td><i>P</i>... | <table><tr><td>Variable</td><td colspan="2">Univariate</td><td colspan="2">Multivariate</td><td colspan="2">Covariate height</td><td colspan="2">Covariate gender</td></tr></table> | <table><tr><td></td><td>B (95% CI)</td><td>P value</td><td>B (95% CI)</td><td>P value</td><td>B (95% CI)</td><td>P value</td><td>B (95% CI)</td><td>P value</td></tr><tr><td>Age</td><td>-0.07 (-0.2; 0.1)</td><td>0.417</td><td></td><td></td><td>0.06 (-0.1; 0.2)</td><td>0.369</td><td>-0.08 (-0.2; 0.06)</td><td>0.258</td><... |
8aafca62f429d6a0e39f2613a1da3dfbcf7fb65c54cdaca1c03ddfb64ebbb2f9.png | simple | <table><tr><td></td><td>User-initiated (n = 17)</td><td>Not user-initiated (n = 3)</td></tr><tr><td>User investigator</td><td>14</td><td>–</td></tr><tr><td>External user involved since formulation</td><td>2</td><td>1</td></tr><tr><td>External user involved only in interpretation</td><td>1</td><td>2</td></tr></tab... | <table><tr><td></td><td>User-initiated (n = 17)</td><td>Not user-initiated (n = 3)</td></tr></table> | <table><tr><td>User investigator</td><td>14</td><td>–</td></tr><tr><td>External user involved since formulation</td><td>2</td><td>1</td></tr><tr><td>External user involved only in interpretation</td><td>1</td><td>2</td></tr></table> |
d0a82cd7823f8482577e9b052a2b136938f70de68037a45b70461f06e2318765.png | complex | <table><tr><td></td><td>Sole C source<sup>a</sup></td><td colspan="4">Glucosinolate decomposition in horseradish extract Residual amount after 16d (%)<sup>b</sup></td><td colspan="4">Decomposition rate in horseradish extract(mM d<sup>-1</sup>)</td><td colspan="2">IC<sub>50</sub> liquid culture(mM)</td></tr><tr><td>ID</... | <table><tr><td></td><td>Sole C sourcea</td><td colspan="4">Glucosinolate decomposition in horseradish extract Residual amount after 16d (%)b</td><td colspan="4">Decomposition rate in horseradish extract(mM d-1)</td><td colspan="2">IC50 liquid culture(mM)</td></tr><tr><td>ID</td><td>SGN</td><td>SGN</td><td>GIB</td><td>G... | <table><tr><td>S2</td><td>+</td><td>0.1 ± 0%</td><td>0 ± 0%</td><td>0 ± 0%</td><td>0 ± 0%</td><td>2.111</td><td>0.015</td><td>0.148</td><td>0.030</td><td>0.0743</td><td>0.0266</td></tr><tr><td>S3</td><td>+</td><td>85.2 ± 4.9%</td><td>75 ± 1.9%</td><td>74.8 ± 0.6%</td><td>83.9 ± 1%</td><td>-</td><td>-</td><td>-</td><td>... |
459af3e20a73ed186a64dfd02104267c6201b89993a422b4363b0d43d95b6750.png | complex | <table><tr><td rowspan="2">Markers</td><td colspan="3">Staining intensity</td></tr><tr><td>LNCaP</td><td>Spheres</td><td>Neuroendocrine cells</td></tr><tr><td>Pancytokeratin</td><td>+/−</td><td>-</td><td>+++</td></tr><tr><td>Neuro-specific enolase</td><td>+/−</td><td>−</td><td>+++</td></tr><tr><td>Ser... | <table><tr><td rowspan="2">Markers</td><td>Staining intensity</td></tr><tr><td>LNCaP</td></tr><tr><td>Pancytokeratin</td><td>+/−</td></tr><tr><td>Neuro-specific enolase</td><td>+/−</td></tr><tr><td>Serotonin</td><td>−</td></tr></table> | <table><tr><td colspan="2">Staining intensity</td></tr><tr><td>Spheres</td><td>Neuroendocrine cells</td></tr><tr><td>-</td><td>+++</td></tr><tr><td>−</td><td>+++</td></tr><tr><td>−</td><td>+</td></tr></table> |
5879d74400fff2a0fee1abde7295eb2e56670744e7ff1627ba2a63e62281075a.png | complex | <table><tr><td></td><td colspan="2">certified CAM</td><td colspan="2">noncertified CAM</td><td colspan="2">COM</td></tr><tr><td></td><td>mean</td><td>median</td><td>mean</td><td>median</td><td>mean</td><td>median</td></tr><tr><td>Number of patients per year</td><td>652</td><td>537</td><td>955</td><td>899</td><td>987</t... | <table><tr><td></td><td colspan="2">certified CAM</td><td colspan="2">noncertified CAM</td><td colspan="2">COM</td></tr><tr><td></td><td>mean</td><td>median</td><td>mean</td><td>median</td><td>mean</td><td>median</td></tr><tr><td>Number of patients per year</td><td>652</td><td>537</td><td>955</td><td>899</td><td>987</t... | <table><tr><td></td><td colspan="2">certified CAM</td><td colspan="2">noncertified CAM</td><td colspan="2">COM</td></tr><tr><td></td><td>mean</td><td>median</td><td>mean</td><td>median</td><td>mean</td><td>median</td></tr><tr><td>Number of consultations per patient and year</td><td>4.6</td><td>4.2</td><td>4.1</td><td>3... |
de88650f784767654f740460224f8791c3fac292a76f58c6a8b555d515d03563.png | simple | <table><tr><td></td><td>EEG normal patients = 53(%)</td><td>EEG abnormal patients = 17(%)</td></tr><tr><td>palpitations, pounding heart, or accelerated heart rate</td><td>44 (83.0)</td><td>13 (76.5)</td></tr><tr><td>sweating</td><td>11 (20.8)</td><td>5 (29.4)</td></tr><tr><td>trembling or shaking</td><td>16 (30.2)</td>... | <table><tr><td></td><td>EEG normal patients = 53(%)</td><td>EEG abnormal patients = 17(%)</td></tr><tr><td>palpitations, pounding heart, or accelerated heart rate</td><td>44 (83.0)</td><td>13 (76.5)</td></tr><tr><td>sweating</td><td>11 (20.8)</td><td>5 (29.4)</td></tr><tr><td>trembling or shaking</td><td>16 (30.2)</td>... | <table><tr><td></td><td>EEG normal patients = 53(%)</td><td>EEG abnormal patients = 17(%)</td></tr><tr><td>sex</td><td>M:17F:36</td><td>M: 3F:14</td></tr></table> |
b437aa1cbb4de1c618f46cd438b08b3db303afaff4a9452232dee00d3233fba7.png | simple | <table><tr><td>Costs per patient in different situation in CHF</td><td>CMR strategy</td><td>“hypothetical” CXA strategy</td></tr><tr><td>All tests performed as outpatient procedures in Switzerland</td><td>1,984</td><td>2,580</td></tr><tr><td>CXA performed as an inpatient procedure in Switzerland</td><td>2,4... | <table><tr><td>Costs per patient in different situation in CHF</td></tr><tr><td>All tests performed as outpatient procedures in Switzerland</td></tr><tr><td>CXA performed as an inpatient procedure in Switzerland</td></tr></table> | <table><tr><td>CMR strategy</td><td>“hypothetical” CXA strategy</td></tr><tr><td>1,984</td><td>2,580</td></tr><tr><td>2,408</td><td>4,638</td></tr></table> |
ce6d01ae0973473cd8314cd28323b2535b8b0481f580c51ae468c9225d561682.png | simple | <table><tr><td>Sensor</td><td>Targeted Gases</td><td>Smell Description</td></tr><tr><td>TGS 880</td><td>volatile vapors from food</td><td>food (while cooking)</td></tr><tr><td>TGS 825</td><td>hydrogen sulfide</td><td>rotten egg, sulfurous smells</td></tr><tr><td>TGS 826</td><td>ammonia</td><td>old rotten urine and fish... | <table><tr><td>Sensor</td><td>Targeted Gases</td><td>Smell Description</td></tr><tr><td>TGS 880</td><td>volatile vapors from food</td><td>food (while cooking)</td></tr><tr><td>TGS 825</td><td>hydrogen sulfide</td><td>rotten egg, sulfurous smells</td></tr><tr><td>TGS 826</td><td>ammonia</td><td>old rotten urine and fish... | <table><tr><td>TGS 2610</td><td>general hydrocarbons</td><td>smell of ripening fruits</td></tr><tr><td>TGS 2602</td><td>ammonia, hydrogen sulfide,ethanol, toluene</td><td>a wide range of smell: from rotten fish to wood fermentattion</td></tr></table> |
c1280e044d183ed076bda2f4629bfa0dfd6dce1ae748443673f66da0cf9e39dd.png | complex | <table><tr><td></td><td></td><td colspan="2">Haplo2Ped</td><td colspan="2">Merlin</td><td></td></tr><tr><td>Chr</td><td>Expected region<sup>a</sup>(bp)</td><td>Detected region (bp)</td><td>LOD score</td><td>Detected region (bp)</td><td>LOD score</td><td>SNPLINK<sup>b</sup></td></tr><tr><td>1</td><td>216,655,820-217,662... | <table><tr><td></td><td></td><td colspan="2">Haplo2Ped</td><td colspan="2">Merlin</td><td></td></tr><tr><td>Chr</td><td>Expected regiona(bp)</td><td>Detected region (bp)</td><td>LOD score</td><td>Detected region (bp)</td><td>LOD score</td><td>SNPLINKb</td></tr><tr><td>1</td><td>216,655,820-217,662,693</td><td>216,631,5... | <table><tr><td></td><td>645,983</td><td>12-54,818,763</td><td>010</td><td>-58,850,202</td><td>1.804</td><td>,726,213</td></tr><tr><td>21</td><td>21,812,513-26,812,202</td><td>21,781,794-27,090,473</td><td>3.010</td><td>21,833,903-26,812,201</td><td>1.778</td><td>21,812,514-26,818,797</td></tr><tr><td>1</td><td>/</td><t... |
163eeedc88e6fcf434458356250a300703605399fe06dc44731b63c212458947.png | complex | <table><tr><td rowspan="2"> </td><td colspan="2">5-HT (ng/mL)</td><td colspan="2">NA (ng/mL)</td><td colspan="2"><i>β</i>-EP (ng/mL)</td></tr><tr><td>Brain tissue</td><td>Plasma </td><td>Brain tissue</td><td>Plasma</td><td>Brain tissue </td><td>Plasma</td></tr><tr><td>Normal group</td><td>144.39 ± 30.36</td><... | <table><tr><td></td><td colspan="2">5-HT (ng/mL)</td><td colspan="2">NA (ng/mL)</td><td colspan="2">β-EP (ng/mL)</td></tr></table> | <table><tr><td></td><td>Brain tissue</td><td>Plasma</td><td>Brain tissue</td><td>Plasma</td><td>Brain tissue</td><td>Plasma</td></tr><tr><td>Normal group</td><td>144.39 ± 30.36</td><td>467.71 ± 86.01</td><td>3.92 ± 0.72</td><td>15.23 ± 2.66</td><td>0.28 ± 0.10</td><td>2.57 ± 0.45</td></tr><tr><td>Model group</td><td>25... |
0f5641ee76026eb455fcac619842a8ca9abec6ff2d64e40338f5369b2f56d43f.png | simple | <table><tr><td>Variables</td><td>B</td><td>SE</td><td>Sig.</td><td>AOR</td><td>95.0 % C.I. for Exp (B)</td></tr><tr><td>Insufficient family time</td><td>.760</td><td>0.338</td><td><i>.025</i></td><td>2.138</td><td>1.102, 4.148</td></tr><tr><td>Unsatisfactory doctor behaviour</td><td>.322</td><td>0.375</td><td>.391</td>... | <table><tr><td>Variables</td><td>B</td><td>SE</td><td>Sig.</td><td>AOR</td><td>95.0 % C.I. for Exp (B)</td></tr></table> | <table><tr><td>Insufficient family time</td><td>.760</td><td>0.338</td><td>.025</td><td>2.138</td><td>1.102, 4.148</td></tr><tr><td>Unsatisfactory doctor behaviour</td><td>.322</td><td>0.375</td><td>.391</td><td>1.380</td><td>0.662, 2.878</td></tr><tr><td>Unsatisfactory manager behaviour</td><td>.692</td><td>0.343</td>... |
b227c0fa2f82081c4079df9eecc5fcc0369597b55fc8e433cfabc4ee364a7462.png | complex | <table><tr><td rowspan="2"> </td><td colspan="3">PinX1</td></tr><tr><td>Positive</td><td>Negative</td><td><i>P</i></td></tr><tr><td><i>Sex</i></td><td> </td><td> </td><td> </td></tr><tr><td>Male</td><td>34</td><td>74</td><td> </td></tr><tr><td>Female</td><td>7</td><td>43</td><td>0.020</td></tr><tr><td><i>Age</i></td><t... | <table><tr><td rowspan="2"></td><td colspan="3">PinX1</td></tr><tr><td>Positive</td><td>Negative</td><td>P</td></tr><tr><td>Sex</td><td></td><td></td><td></td></tr><tr><td>Male</td><td>34</td><td>74</td><td></td></tr><tr><td>Female</td><td>7</td><td>43</td><td>0.020</td></tr><tr><td>Age</td><td></td><td></td><td></td><... | <table><tr><td>No</td><td>26</td><td>50</td><td>0.023</td></tr><tr><td>T stage</td><td></td><td></td><td></td></tr><tr><td>T1</td><td>6</td><td>41</td><td></td></tr><tr><td>T2 + T3</td><td>35</td><td>76</td><td>0.013</td></tr><tr><td>N stage</td><td></td><td></td><td></td></tr><tr><td>N0</td><td>46</td><td>24</td><td><... |
cc800ef143a7d45c6c92eee545b521988b3267a136c477e31686e86d81cbc25b.png | simple | <table><tr><td></td><td>2010</td><td>2011</td><td>2012</td><td>2013</td></tr><tr><td>Birth attendant, N (%)</td><td></td><td></td><td></td><td></td></tr><tr><td>Physician</td><td>1,241 (32.1)</td><td>1,547 (37.8)</td><td>1,851 (45.4)</td><td>2,416 (52.9)</td></tr><tr><td>Nurse/Midwife/HW</td><td>39 (1.0)</td><td>96 (2.... | <table><tr><td></td><td>2010</td><td>2011</td><td>2012</td><td>2013</td></tr><tr><td>Birth attendant, N (%)</td><td></td><td></td><td></td><td></td></tr><tr><td>Physician</td><td>1,241 (32.1)</td><td>1,547 (37.8)</td><td>1,851 (45.4)</td><td>2,416 (52.9)</td></tr><tr><td>Nurse/Midwife/HW</td><td>39 (1.0)</td><td>96 (2.... | <table><tr><td>Vaginal assisted</td><td>4 (0.1)</td><td>4 (0.1)</td><td>12 (0.3)</td><td>0 (0.0)</td></tr><tr><td>C-section</td><td>515 (13.3)</td><td>682 (16.7)</td><td>809 (19.9)</td><td>1,109 (24.3)</td></tr><tr><td>Maternal antibiotics, N (%)</td><td>405 (12.6)</td><td>675 (17.0)</td><td>950 (24.2)</td><td>1,373 (3... |
c0eabd9ad46508ce6666bc7ff7598957651a35c43bb4a712cbca0805f320e778.png | complex | <table><tr><td>Toxicity</td><td colspan="6">Grade</td></tr><tr><td></td><td>0</td><td>1</td><td>2</td><td>3</td><td>4</td><td>≥Grade 3 (%)</td></tr><tr><td>Leukopenia</td><td>26</td><td>16</td><td>17</td><td>3</td><td>0</td><td>5</td></tr><tr><td>Neutropenia</td><td>32</td><td>14</td><td>11</td><td>5</td><td>0</t... | <table><tr><td>Toxicity</td><td colspan="6">Grade</td></tr><tr><td></td><td>0</td><td>1</td><td>2</td><td>3</td><td>4</td><td>≥Grade 3 (%)</td></tr><tr><td>Leukopenia</td><td>26</td><td>16</td><td>17</td><td>3</td><td>0</td><td>5</td></tr><tr><td>Neutropenia</td><td>32</td><td>14</td><td>11</td><td>5</td><td>0</td><td>... | <table><tr><td>Dermatitis</td><td>1</td><td>58</td><td>2</td><td>1</td><td>0</td><td>2</td></tr><tr><td>Hoarseness</td><td>45</td><td>12</td><td>4</td><td>1</td><td>0</td><td>2</td></tr></table> |
54ac50f4d11ed300d98c9603590bea57828d041242ebb56bc0170cdd99173d89.png | complex | <table><tr><td>Groups</td><td colspan="2">Number of patients</td><td colspan="2">Age, y (Mean ± SD)</td></tr><tr><td rowspan="2">PEX</td><td rowspan="2">39</td><td>F—18</td><td rowspan="2">76.49 ± 6.54</td><td>F—79.44 ± 5.24</td></tr><tr><td>M—21</td><td>M—73.95 ± 6.59</td></... | <table><tr><td>Groups</td><td colspan="2">Number of patients</td><td colspan="2">Age, y (Mean ± SD)</td></tr></table> | <table><tr><td rowspan="2">PEX</td><td rowspan="2">39</td><td>F—18</td><td rowspan="2">76.49 ± 6.54</td><td>F—79.44 ± 5.24</td></tr><tr><td>M—21</td><td>M—73.95 ± 6.59</td></tr><tr><td rowspan="2">PEXG</td><td rowspan="2">37</td><td>F—18</td><td rowspan="2">78.22 ± 7.58</td><td>F—77.06 ± 6.58</td></tr><tr><td>M—19</td>... |
90a31180734c8c8c5084121d9b335f320b436b6f01557614fb633928ce08e996.png | complex | <table><tr><td>Study</td><td>Subgroups by MP status</td><td>Exposure categories (<i>n</i>)</td><td>Oldest/Youngest age category</td><td colspan="2">RR (95% CI) for oldest vs. youngest age category</td></tr><tr><td></td><td></td><td></td><td></td><td>ER<sup>+</sup>PR<sup>+</sup></td><td>ER<sup>-</sup>PR<sup>-</sup></td>... | <table><tr><td>Study</td><td>Subgroups by MP status</td><td>Exposure categories (n)</td><td>Oldest/Youngest age category</td><td colspan="2">RR (95% CI) for oldest vs. youngest age category</td></tr><tr><td></td><td></td><td></td><td></td><td>ER+PR+</td><td>ER-PR-</td></tr><tr><td colspan="6">Cohort studies</td></tr><t... | <table><tr><td colspan="6">ital-based case-control studies</td></tr><tr><td>[15]</td><td>All women</td><td>Per 2 years↑</td><td>2 years' increase</td><td>0.83 (0.68–1.01)</td><td>1.11 (0.91–1.36)</td></tr><tr><td>16</td><td>All women</td><td>3</td><td>≥14/<12</td><td>1.0 (0.53–-2.00)</td><td>1.43 (0.71–2.50)</td></tr><... |
87873dde909ad18a54dc1be97b108f6f2071bf0414f6541d851a6dd8a6ac9379.png | simple | <table><tr><td>Test substance</td><td>Tomato extract in squalane</td><td>Tomato extract in hydrogenated polydecene</td><td><i>Dunaliella</i> extract in hydrogenated polydecene</td></tr><tr><td>Reactions noted</td><td>None</td><td>None</td><td>None</td></tr><tr><td># reactive subjects (%)</td><td>0 (0%)</td><td>0 (0%)</... | <table><tr><td>Test substance</td><td>Tomato extract in squalane</td><td>Tomato extract in hydrogenated polydecene</td><td>Dunaliella extract in hydrogenated polydecene</td></tr><tr><td>Reactions noted</td><td>None</td><td>None</td><td>None</td></tr><tr><td># reactive subjects (%)</td><td>0 (0%)</td><td>0 (0%)</td><td>... | <table><tr><td>Test substance</td><td>Tomato extract in squalane</td><td>Tomato extract in hydrogenated polydecene</td><td>Dunaliella extract in hydrogenated polydecene</td></tr><tr><td>Conclusion</td><td>Very good skin compatibility/nonirritant</td><td>Very good skin compatibility/nonirritant</td><td>Very good skin co... |
ce128344d35e425ba160bb6bb32e6639bd0992a0ad84aa8c4ed3d8d248df9739.png | complex | <table><tr><td>Antibiotic</td><td colspan="2">Proportion susceptible (%)</td></tr><tr><td> </td><td>MSSA (n = 80)</td><td>MRSA (n = 6)</td></tr><tr><td>Cefoxitin</td><td>100</td><td>0</td></tr><tr><td>Benzylpenicillin</td><td>26</td><td>0</td></tr><tr><td>Co-trimoxazole</td><td>60</td><td>0</td></tr><tr><td>Tetracyclin... | <table><tr><td>Antibiotic</td><td colspan="2">Proportion susceptible (%)</td></tr><tr><td></td><td>MSSA (n = 80)</td><td>MRSA (n = 6)</td></tr></table> | <table><tr><td>Cefoxitin</td><td>100</td><td>0</td></tr><tr><td>Benzylpenicillin</td><td>26</td><td>0</td></tr><tr><td>Co-trimoxazole</td><td>60</td><td>0</td></tr><tr><td>Tetracycline</td><td>85</td><td>0</td></tr><tr><td>Gentamicin</td><td>99</td><td>0</td></tr><tr><td>Ciprofloxacin</td><td>100</td><td>0</td></tr><tr... |
480fc69c231ce1047b70be246c51c4d3ec953c67ecd648087d130a5e0e826c81.png | simple | <table><tr><td>Polymer Type</td><td>LOD</td><td>Response Time/Recovery Time</td><td>Transducing Mechanism</td><td>Ref.</td></tr><tr><td>PPy nanoparticles</td><td>5 ppm</td><td>Less than 1 s/2 s</td><td>Chemiresistive</td><td>[58]</td></tr><tr><td>Multidimensional PPy nanotubes</td><td>0.01 ppm</td><td>Less than 1 s/55&... | <table><tr><td>Polymer Type</td><td>LOD</td><td>Response Time/Recovery Time</td><td>Transducing Mechanism</td><td>Ref.</td></tr><tr><td>PPy nanoparticles</td><td>5 ppm</td><td>Less than 1 s/2 s</td><td>Chemiresistive</td><td>[58]</td></tr><tr><td>Multidimensional PPy nanotubes</td><td>0.01 ppm</td><td>Less than 1 s/55–... | <table><tr><td>PPy/graphene nanocomposite decorated with TiO2 nanoparticles</td><td>1 ppm</td><td>~36 s/~16 s for 50 ppm</td><td>Chemiresistive</td><td>[116]</td></tr><tr><td>Au/PPy nanopeapods</td><td>0.007 ppmv</td><td>~15 min for 5 ppmv/did not reach Ro value</td><td>Chemiresistive</td><td>[117]</td></tr></table> |
b0100cd964f5c56840a0f9a54fe6b6ff953a7302a1d866bd3dd2aefa92df8631.png | simple | <table><tr><td>Variable</td><td>HIV-1-seronegative psoriasis</td><td>HIV-1-related psoriasis</td><td>References</td></tr><tr><td>Frequency</td><td>1-3%</td><td>Similar to HIV-seronegative population</td><td>[54,55]</td></tr><tr><td>Severity</td><td>Mild-moderate</td><td>Moderate-severe</td><td>[62]</td></tr><tr><td>Cli... | <table><tr><td>Variable</td><td>HIV-1-seronegative psoriasis</td><td>HIV-1-related psoriasis</td><td>References</td></tr><tr><td>Frequency</td><td>1-3%</td><td>Similar to HIV-seronegative population</td><td>[54,55]</td></tr><tr><td>Severity</td><td>Mild-moderate</td><td>Moderate-severe</td><td>[62]</td></tr><tr><td>Cli... | <table><tr><td>Presence of psoriatic arthritis</td><td>5-20%</td><td>23%-50%</td><td>[54,55]</td></tr><tr><td>Mean age of presentation</td><td>>30 years</td><td>=30 years</td><td>[63]</td></tr><tr><td>Family history</td><td>Frequent</td><td>Variable</td><td>[64]</td></tr><tr><td>Presence of HLA-Cw*0602</td><td>25%</td>... |
bd68894349e1251d1922305a293510be9fe3e50fe467603a026af5cb01c1ef41.png | complex | <table><tr><td colspan="2">Characteristic</td><td colspan="4">Region</td><td>Overall</td></tr><tr><td> </td><td> </td><td>Southern</td><td>Highlands</td><td>Momase</td><td>Islands</td><td> </td></tr><tr><td colspan="2">Female n (%)</td><td>64 (51)</td><td>50 (46)</td><td>56 (46)</td><td>51 (47)</td><td>221 (47)</td></t... | <table><tr><td colspan="2">Characteristic</td><td colspan="4">Region</td><td>Overall</td></tr><tr><td></td><td></td><td>Southern</td><td>Highlands</td><td>Momase</td><td>Islands</td><td></td></tr><tr><td colspan="2">Female n (%)</td><td>64 (51)</td><td>50 (46)</td><td>56 (46)</td><td>51 (47)</td><td>221 (47)</td></tr><... | <table><tr><td></td><td>16+ yrs</td><td>35 (28)</td><td>41 (40)</td><td>32 (27)</td><td>24 (22)</td><td>132 (29)</td></tr></table> |
cc7e7bb77725523efc9a0c1f2d20134a765065e09757563ee06345aa3a1b2b8e.png | simple | <table><tr><td>Group</td><td>Hoffman cluster</td><td>Species, subspecies, or complex</td><td>Type strain</td><td>Accession no.</td><td>No. of strains</td></tr><tr><td>A</td><td>VI</td><td><i>E. xiangfangensis</i></td><td>LMG 27195<sup>a</sup></td><td>NZ_CP017183.1</td><td>3</td></tr><tr><td>B</td><td>VIII</td><td><i>E.... | <table><tr><td>Group</td></tr><tr><td>A</td></tr><tr><td>B</td></tr><tr><td>C</td></tr><tr><td>D</td></tr><tr><td>E</td></tr><tr><td>F</td></tr><tr><td>G</td></tr><tr><td>H</td></tr><tr><td>I</td></tr><tr><td>J</td></tr><tr><td>K</td></tr><tr><td>L</td></tr><tr><td>M</td></tr><tr><td>N</td></tr><tr><td>O</td></tr><tr><... | <table><tr><td>Hoffman cluster</td><td>Species, subspecies, or complex</td><td>Type strain</td><td>Accession no.</td><td>No. of strains</td></tr><tr><td>VI</td><td>E. xiangfangensis</td><td>LMG 27195a</td><td>NZ_CP017183.1</td><td>3</td></tr><tr><td>VIII</td><td>E. hormaechei subsp. steigerwaltii</td><td>DSM 16691a</td... |
deaa8e348011dbd4018aa567c9bb1eb5c361d8644db74927d5e27f9ab26c6cd1.png | complex | <table><tr><td rowspan="3"></td><td colspan="2">GDM 2007–2008</td><td colspan="2">No GDM 2007–2008</td><td rowspan="3">p value</td></tr><tr><td colspan="2">(n = 62,958)</td><td colspan="2">(n = 1,452,429)</td></tr><tr><td>Size</td><td>(%)</td><td>Size</td><td>(%)</td></tr><tr><td>Age</td><td></td><td></td><... | <table><tr><td rowspan="3"></td><td colspan="2">GDM 2007–2008</td><td colspan="2">No GDM 2007–2008</td><td rowspan="3">p value</td></tr><tr><td colspan="2">(n = 62,958)</td><td colspan="2">(n = 1,452,429)</td></tr><tr><td>Size</td><td>(%)</td><td>Size</td><td>(%)</td></tr></table> | <table><tr><td>Age</td><td></td><td></td><td></td><td></td><td><0.0001</td></tr><tr><td><20</td><td>520</td><td>0.83</td><td>42,313</td><td>2.91</td><td></td></tr><tr><td>20–29</td><td>21,471</td><td>34.10</td><td>706,688</td><td>48.66</td><td></td></tr><tr><td>30–39</td><td>35,922</td><td>57.06</td><td>656,693</td><td... |
5dc2b9d89bc614985b245ae403e7617f8ebb34de2c79841b7b23e9ece41bbf96.png | complex | <table><tr><td>Variables</td><td>Patients number</td><td>%</td></tr><tr><td>Age (mean ± SD) days</td><td colspan="2">6.7 ± 2.3</td></tr><tr><td>Body weight (mean ± SD) kg</td><td colspan="2">3.4 ± 0.3</td></tr><tr><td colspan="3">Gender</td></tr><tr><td> Male</td><td>13</td><td>68.4</td></tr><tr><td... | <table><tr><td>Variables</td><td>Patients number</td><td>%</td></tr><tr><td>Age (mean ± SD) days</td><td colspan="2">6.7 ± 2.3</td></tr><tr><td>Body weight (mean ± SD) kg</td><td colspan="2">3.4 ± 0.3</td></tr><tr><td colspan="3">Gender</td></tr><tr><td>Male</td><td>13</td><td>68.4</td></tr><tr><td>Female</td><td>6</td... | <table><tr><td>Variables</td><td>Patients number</td><td>%</td></tr><tr><td>Cx,R</td><td>IM)</td><td></td></tr><tr><td>2L,Cx; 2R</td><td>3 (1RP, 1IM)</td><td>15.8</td></tr><tr><td>2R; 2L,Cx</td><td>1 (RP)</td><td>5.3</td></tr><tr><td colspan="3">Relation of gas</td></tr><tr><td>Anteroposterior</td><td>4</td><td>21.1</t... |
af38c4b96abf1ee8fea24c6f3251462f4ec5236e9258e011b4fed4e0e7224131.png | complex | <table><tr><td></td><td></td><td>Odds ratio</td><td colspan="2">95 % confidence intervals</td></tr><tr><td></td><td></td><td></td><td>Lower</td><td>Upper</td></tr><tr><td>Tobacco</td><td>Follow-up vs. Baseline</td><td>1.020</td><td>0.223</td><td>4.661</td></tr><tr><td>Nutrition</td><td>Follow-up vs. Baseline</td><td>1.... | <table><tr><td></td><td></td><td>Odds ratio</td><td colspan="2">95 % confidence intervals</td></tr><tr><td></td><td></td><td></td><td>Lo</td><td>Uppe</td></tr></table> | <table><tr><td></td><td></td><td></td><td>wer</td><td>r</td></tr><tr><td>Tobacco</td><td>Follow-up vs. Baseline</td><td>1.020</td><td>0.223</td><td>4.661</td></tr><tr><td>Nutrition</td><td>Follow-up vs. Baseline</td><td>1.555</td><td>0.814</td><td>2.972</td></tr><tr><td>Physical activity</td><td>Follow-up vs. Baseline<... |
53529ac023b1ee483f3c74ed9b87a3a53d950c010c03766174617674b28f75e1.png | complex | <table><tr><td>Populations and risk factors</td><td colspan="2">ET-1 (nM/L)</td><td><i>p</i></td></tr><tr><td rowspan="2">Gender</td><td>Men (n = 121)</td><td>17.4 ± 4.6</td><td rowspan="2"><0.00001</td></tr><tr><td>Women (n = 36)</td><td>7.8 ± 2.3</td></tr><tr><td rowspan="2">Hypertension</td><td>Yes (n =... | <table><tr><td>Populations and risk factors</td><td colspan="2">ET-1 (nM/L)</td><td>p</td></tr><tr><td rowspan="2">Gender</td><td>Men (n = 121)</td><td>17.4 ± 4.6</td><td rowspan="2"><0.00001</td></tr><tr><td>Women (n = 36)</td><td>7.8 ± 2.3</td></tr><tr><td rowspan="2">Hypertension</td><td>Yes (n = 138)</td><td>16.4 ±... | <table><tr><td rowspan="2">Dyslipidemia</td><td>Yes (n = 63)</td><td>11.8 ± 1.6</td><td rowspan="2"><0.00001</td></tr><tr><td>No (n = 94)</td><td>17 .5 ± 4.6</td></tr><tr><td rowspan="2">Alcohol</td><td>Yes (n = 52)</td><td>16 ± 4.1</td><td rowspan="2">NS</td></tr><tr><td>No (n = 105)</td><td>14.8 ± 3.8</td></tr><tr><t... |
d1a582c03e2e17d3caaff01332c6f63c93f7bd1fbbecc7e59e11ea452481d351.png | simple | <table><tr><td>Diet composition</td><td>20% animal protein</td><td>10% animal pro+tein</td><td>20% plant protein</td><td>10% plant protein</td></tr><tr><td>Total energy value (kcal/g)</td><td>3.7</td><td>3.7</td><td>3.7</td><td>3.7</td></tr><tr><td>Carbohydrate (%Kcal)</td><td>62.93</td><td>73.23</td><td>63.15</td><td>... | <table><tr><td>Diet composition</td><td>20% animal protein</td><td>10% animal pro+tein</td></tr><tr><td>Total energy value (kcal/g)</td><td>3.7</td><td>3.7</td></tr><tr><td>Carbohydrate (%Kcal)</td><td>62.93</td><td>73.23</td></tr><tr><td>Fat (%kcal)</td><td>16.97</td><td>16.97</td></tr><tr><td>Protein (%Kcal)</td><td>... | <table><tr><td>20% plant protein</td><td>10% plant protein</td></tr><tr><td>3.7</td><td>3.7</td></tr><tr><td>63.15</td><td>73.06</td></tr><tr><td>16.87</td><td>16.74</td></tr><tr><td>19.98</td><td>10.20</td></tr><tr><td>21.2</td><td>10.6</td></tr><tr><td>7.9</td><td>4.0</td></tr><tr><td>3.9</td><td>1.9</td></tr><tr><td... |
d9b70091e7d1930ad1b05cfd6203d691b432a2ef33bd3657a9de13556a0f67e7.png | simple | <table><tr><td> </td><td> </td><td><i><underline>Mean (SD)</underline></i></td></tr><tr><td>Age</td><td>(Year)</td><td>43.91 (15.4)</td></tr><tr><td>Pain intensity<sup>*</sup></td><td>(0–10)</td><td>4.11 (1.9)</td></tr><tr><td>Physical disability<sup>**</sup></td><td>(0–24)</td><td>8.78 (5.3)</td></tr><tr><... | <table><tr><td></td><td></td></tr><tr><td>Age</td><td>(Year)</td></tr><tr><td>Pain intensity*</td><td>(0–10)</td></tr><tr><td>Physical disability**</td><td>(0–24)</td></tr><tr><td>Depression***</td><td>(0–42)</td></tr><tr><td>Anxiety≠</td><td>(0–42)</td></tr><tr><td>Stress±</td><td>(0–42)</td></tr><tr><td>Fatigue†</td... | <table><tr><td>Mean (SD)</td></tr><tr><td>43.91 (15.4)</td></tr><tr><td>4.11 (1.9)</td></tr><tr><td>8.78 (5.3)</td></tr><tr><td>8.75 (9.9)</td></tr><tr><td>6.55 (8.4)</td></tr><tr><td>13.08 (9.8)</td></tr><tr><td>32.49 (12.3)</td></tr><tr><td>7.92 (3.8)</td></tr><tr><td>11.25 (6.4)</td></tr><tr><td>7.26 (5.2)</td></tr>... |
b11a924172c22e8d19f8f9acc1df01d461122a810a7d5897102795767b34d61e.png | complex | <table><tr><td></td><td colspan="2">Full sample (n = 14,798)</td><td colspan="2">Restricted analytic sample (n = 11,733)</td></tr><tr><td></td><td><i>percent</i></td><td><i>std error</i></td><td><i>percent</i></td><td><i>std error</i></td></tr><tr><td><i>Age</i></td><td></td><td></td><td></td><td></td></tr><tr><td>18&#... | <table><tr><td></td><td colspan="2">Full sample (n = 14,798)</td><td colspan="2">Restricted analytic sample (n = 11,733)</td></tr><tr><td></td><td>percent</td><td>std error</td><td>percent</td><td>std error</td></tr><tr><td>Age</td><td></td><td></td><td></td><td></td></tr><tr><td>18–24</td><td>17</td><td>0.6</td><td>18... | <table><tr><td></td><td colspan="2">Full sample (n = 14,798)</td><td colspan="2">Restricted analytic sample (n = 11,733)</td></tr><tr><td></td><td>percent</td><td>std error</td><td>percent</td><td>std error</td></tr><tr><td>Race/ethnicity</td><td></td><td></td><td></td><td></td></tr><tr><td>White</td><td>74</td><td>1</... |
101756274042bb558ea624d7579826c80f11dece9a3131493e4bd15a1dc88b96.png | simple | <table><tr><td>Variable</td><td>Number of cases</td><td>%</td></tr><tr><td>Gender</td><td></td><td></td></tr><tr><td> Male</td><td>116</td><td>54</td></tr><tr><td> Female</td><td>98</td><td>46</td></tr><tr><td>Age, y</td><td></td><td></td></tr><tr><td> < 70</td><td>120</td><td>56</td></tr><tr><td> ≥ 70</td><td... | <table><tr><td>Variable</td><td>Number of cases</td></tr><tr><td>Gender</td><td></td></tr><tr><td>Male</td><td>116</td></tr><tr><td>Female</td><td>98</td></tr><tr><td>Age, y</td><td></td></tr><tr><td>< 70</td><td>120</td></tr><tr><td>≥ 70</td><td>94</td></tr><tr><td>T-category</td><td></td></tr><tr><td>T2</td><td>33</t... | <table><tr><td>%</td></tr><tr><td></td></tr><tr><td>54</td></tr><tr><td>46</td></tr><tr><td></td></tr><tr><td>56</td></tr><tr><td>44</td></tr><tr><td></td></tr><tr><td>15</td></tr><tr><td>85</td></tr><tr><td></td></tr><tr><td>49</td></tr><tr><td>51</td></tr><tr><td>73</td></tr></table> |
9fbf079761b461a40050ebcc7a3bd22891cb5a37876100ef1ee6906ee94f926f.png | complex | <table><tr><td>Variable</td><td>Variable groups</td><td>Treatment sought (%)</td><td>COR (95% CI)</td><td>AOR (95% CI)</td></tr><tr><td rowspan="2">Age of caregivers</td><td><30</td><td>103 (92.0)</td><td>2.5 (1.02–5.91)*</td><td>3.40 (1.27–9.10)**</td></tr><tr><td><underline>></underline>30</td><td>7... | <table><tr><td>Variable</td><td>Variable groups</td><td>Treatment sought (%)</td><td>COR (95% CI)</td><td>AOR (95% CI)</td></tr><tr><td rowspan="2">Age of caregivers</td><td><30</td><td>103 (92.0)</td><td>2.5 (1.02–5.91)*</td><td>3.40 (1.27–9.10)**</td></tr><tr><td>>30</td><td>70 (82.4)</td><td>1.00</td><td>1.00</td></... | <table><tr><td>Variable</td><td>Variable groups</td><td>Treatment sought (%)</td><td>COR (95% CI)</td><td>AOR (95% CI)</td></tr><tr><td rowspan="2">ia treatment</td><td>w</td><td>.1)</td><td>0</td><td></td></tr><tr><td>High</td><td>86 (89.6)</td><td>1.38 (0.58–3.29)</td><td></td></tr><tr><td rowspan="2">Perceived barri... |
79d8cb4a3b583c3f760820489bc8aeb11fc48f85663a1e9946ba028d408135a4.png | complex | <table><tr><td>SOCIODEMOGRAPHIC AND CLINICAL CHARACTERISTICS</td><td colspan="6">QUALITY OF LIFE</td></tr><tr><td></td><td>Physical</td><td>Psychological</td><td>Level of independence</td><td>Social relationships</td><td>Environment</td><td>Spirituality/Religion/Personal beliefs</td></tr><tr><td>Age*</td><td>-0.01</td>... | <table><tr><td>SOCIODEMOGRAPHIC AND CLINICAL CHARACTERISTICS</td><td colspan="6">QUALITY OF LIFE</td></tr><tr><td></td><td>Physical</td><td>Psychological</td><td>Level of independence</td><td>Social relationships</td><td>Environment</td><td>Spirituality/Religion/Personal beliefs</td></tr><tr><td>Age*</td><td>-0.01</td>... | <table><tr><td>SOCIODEMOGRAPHIC AND CLINICAL CHARACTERISTICS</td><td colspan="6">QUALITY OF LIFE</td></tr><tr><td></td><td>Physical</td><td>Psychological</td><td>Level of independence</td><td>Social relationships</td><td>Environment</td><td>Spirituality/Religion/Personal beliefs</td></tr><tr><td>Fasting Glucose mmol/L*... |
53eefa60bb5dcc1cec563ca61fffd2016a32f1b3acfb950ecd327bdf0d4d0cbe.png | simple | <table><tr><td>Tissue</td><td>Male <i>P</i> Value</td><td>Male<i>ρ</i></td><td>Female <i>P-</i>Value</td><td>Female<i>ρ</i></td></tr><tr><td>Brain</td><td>8.71E−07</td><td>0.05504</td><td>2.81E−08</td><td>0.06247</td></tr><tr><td>Cerebellum</td><td>1.71E−19</td><td>0.10246</td><td>9.25Eͨ... | <table><tr><td>Tissue</td><td>Male P Value</td><td>Maleρ</td><td>Female P-Value</td><td>Femaleρ</td></tr></table> | <table><tr><td>Brain</td><td>8.71E−07</td><td>0.05504</td><td>2.81E−08</td><td>0.06247</td></tr><tr><td>Cerebellum</td><td>1.71E−19</td><td>0.10246</td><td>9.25E−21</td><td>0.10539</td></tr><tr><td>Kidney</td><td>3.97E−126</td><td>0.26420</td><td>3.37E−07</td><td>0.05751</td></tr><tr><td>Heart</td><td>4.13E−66</td><td>... |
f9cc263cd6d194ea8722f387813ecf2afb2d8050c4a179a46e6eb08b0561a7b3.png | complex | <table><tr><td rowspan="2">Year*</td><td rowspan="2"><i>N</i><sub>a</sub>†</td><td colspan="3">Microsatellites – <i>N</i><sub>b</sub></td><td colspan="2">MtDNA – <i>N</i><sub>bf</sub></td></tr><tr><td>mlne‡</td><td>Tempo <i>F</i><sub>S</sub>§</td><td>ldne¶</td><td>mlne‡</td><td><... | <table><tr><td rowspan="2">Year*</td><td rowspan="2">Na†</td><td colspan="3">Microsatellites – Nb</td><td colspan="2">MtDNA – Nbf</td></tr><tr><td>mlne‡</td><td>Tempo FS§</td><td>ldne¶</td><td>mlne‡</td><td>Fc**</td></tr><tr><td>1997</td><td>7532 (5359, 9997)</td><td>1609 (867, 7408)</td><td>711 (398, 3362)</td><td>107... | <table><tr><td rowspan="2">Year*</td><td rowspan="2">Na†</td><td colspan="3">Microsatellites – Nb</td><td colspan="2">MtDNA – Nbf</td></tr><tr><td>mlne‡</td><td>Tempo FS§</td><td>ldne¶</td><td>mlne‡</td><td>Fc**</td></tr><tr><td>2009</td><td>1183 (679, 2763)</td><td>1587 (881, 6219)</td><td>840 (425, 34 487)</td><td>82... |
f911743f5bd88d1c5bf8496320bafd1e59154f955ffd614507ae3abb518eb5bb.png | simple | <table><tr><td>Demographics</td><td>Week 4</td><td>Week 8</td><td>Week 12</td></tr><tr><td>Age (year)</td><td></td><td></td><td></td></tr><tr><td><i>n</i></td><td>159</td><td>129</td><td>106</td></tr><tr><td> Mean ± SD</td><td>63.8 ± 13.1</td><td>63.9 ± 13.5</td><td>63.4 ± 13.8</td></tr><tr><td> Int... | <table><tr><td>Demographics</td><td>Week 4</td><td>Week 8</td><td>Week 12</td></tr><tr><td>Age (year)</td><td></td><td></td><td></td></tr><tr><td>n</td><td>159</td><td>129</td><td>106</td></tr><tr><td>Mean ± SD</td><td>63.8 ± 13.1</td><td>63.9 ± 13.5</td><td>63.4 ± 13.8</td></tr><tr><td>Interquartiles</td><td>54–74</td... | <table><tr><td>Interquartiles</td><td>2–5</td><td>2–5</td><td>2–5</td></tr><tr><td>Median (range)</td><td>3.0 (0–10)</td><td>3.0 (0–9)</td><td>3.0 (0–9)</td></tr><tr><td>Current pain</td><td></td><td></td><td></td></tr><tr><td>n</td><td>159</td><td>129</td><td>106</td></tr><tr><td>Mean ± SD</td><td>2.69 ± 2.49</td><td>... |
e6ecf114830e532f028e89b7f275578facb10f51d5811bc86cb4c9b8eca4bdfc.png | simple | <table><tr><td>Disease Duration (Years)</td><td>Number (n)</td><td>Age (Years, Mean)</td><td>Female * (%)</td><td>BMI * (kg/m<sup>2</sup>, Mean)</td><td>Pos. Fam. History * (%)</td><td>RF Pos. * (%)</td><td>ACPA Pos. * (%)</td><td>Rheumatoid Nodules * (%)</td><td>Extra-art. Manifest * (%)</td><td>MTX Pre-exposed * (%)<... | <table><tr><td>Disease Duration</td><td>Nu</td><td>Age (Years, Me</td><td>Female </td><td>BMI </td><td>P</td><td>RF Pos.</td><td>A</td><td>Rheumatoid Nodul</td><td>Extra-ar</td><td>MTX Pre-expo</td><td>TNF Pr</td></tr></table> | <table><tr><td> (Years)</td><td>mber (n)</td><td>an)</td><td>* (%)</td><td>* (kg/m2, Mean)</td><td>os. Fam. History * (%)</td><td> * (%)</td><td>CPA Pos. * (%)</td><td>es * (%)</td><td>t. Manifest * (%)</td><td>sed * (%)</td><td>e-exposed * (%)</td></tr><tr><td>all</td><td>7850</td><td>59.9</td><td>74.4</td><td>26.0</t... |
5d560703e1a427ef1f2f015fa4ee9e449a447cf1c59f575d2cfcd1d43f2f81cd.png | simple | <table><tr><td>HPA</td><td>Position</td><td>Common allele</td><td>Rare allele</td><td>Residue variety in β-integrins</td></tr><tr><td>1</td><td>33</td><td>Leu</td><td>Pro (Val)</td><td>A, D, E, G, K, L, M, N, P, Q, S, T, V, Y</td></tr><tr><td>4</td><td>143</td><td>Arg</td><td>Gln</td><td>A, E, G, K, N, Q, R, S, T,... | <table><tr><td>HPA</td><td>Position</td><td>Common allele</td><td>Rare allele</td><td>Residue variety in β-integrins</td></tr></table> | <table><tr><td>1</td><td>33</td><td>Leu</td><td>Pro (Val)</td><td>A, D, E, G, K, L, M, N, P, Q, S, T, V, Y</td></tr><tr><td>4</td><td>143</td><td>Arg</td><td>Gln</td><td>A, E, G, K, N, Q, R, S, T, V</td></tr><tr><td>6</td><td>489</td><td>Arg</td><td>Gln</td><td>A, D, E, G, H, K, N, P, Q, R, S, T, V</td></tr><tr><td>7</... |
45efeb9d6c64991895700dbb52735e6db53058fa2621e4e3a67d970c9c5ffe53.png | complex | <table><tr><td>Demographic or Clinical Characteristic</td><td colspan="2">No. of Patients (<i>N</i>= 48)</td><td>%</td></tr><tr><td>Age, years</td><td></td><td></td><td></td></tr><tr><td> Median</td><td></td><td>56.6</td><td></td></tr><tr><td> Range</td><td></td><td>29-77</td><td></td></tr><tr><td>ECOG performance stat... | <table><tr><td>Demographic or Clinical Characteristic</td><td colspan="2">No. of Patients (N= 48)</td><td>%</td></tr><tr><td>Age, years</td><td></td><td></td><td></td></tr><tr><td>Median</td><td></td><td>56.6</td><td></td></tr><tr><td>Range</td><td></td><td>29-77</td><td></td></tr><tr><td>ECOG performance status</td><t... | <table><tr><td>Primary tumor intact</td><td>11</td><td></td><td>23</td></tr><tr><td>Skin ulceration</td><td>19</td><td></td><td>40</td></tr><tr><td>Lymph node stations clinically involved</td><td></td><td></td><td></td></tr><tr><td>Groin only (stage III)</td><td>11</td><td></td><td>23</td></tr><tr><td>Deep inguinal or ... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.